<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article" dtd-version="1.3"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">iScience</journal-id><journal-id journal-id-type="iso-abbrev">iScience</journal-id><journal-title-group><journal-title>iScience</journal-title></journal-title-group><issn pub-type="epub">2589-0042</issn><publisher><publisher-name>Elsevier</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmc">PMC9436744</article-id><article-id pub-id-type="pii">S2589-0042(22)01192-0</article-id><article-id pub-id-type="doi">10.1016/j.isci.2022.104920</article-id><article-id pub-id-type="publisher-id">104920</article-id><article-categories><subj-group subj-group-type="heading"><subject>Perspective</subject></subj-group></article-categories><title-group><article-title>Mitochondrial protein synthesis and the bioenergetic cost of neurodevelopment</article-title></title-group><contrib-group><contrib contrib-type="author" id="au1"><name><surname>B&#x000fc;low</surname><given-names>Pernille</given-names></name><xref rid="aff1" ref-type="aff">1</xref><xref rid="fn1" ref-type="fn">3</xref></contrib><contrib contrib-type="author" id="au2"><name><surname>Patgiri</surname><given-names>Anupam</given-names></name><xref rid="aff2" ref-type="aff">2</xref></contrib><contrib contrib-type="author" id="au3"><name><surname>Faundez</surname><given-names>Victor</given-names></name><email>vfaunde@emory.edu</email><xref rid="aff1" ref-type="aff">1</xref><xref rid="cor1" ref-type="corresp">&#x02217;</xref></contrib><aff id="aff1"><label>1</label>Department of Cell Biology, Emory University School of Medicine, Atlanta, GA 30322, USA</aff><aff id="aff2"><label>2</label>Department of Pharmacology and Chemical Biology, Emory University School of Medicine, Atlanta, GA 30322, USA</aff></contrib-group><author-notes><corresp id="cor1"><label>&#x02217;</label>Corresponding author <email>vfaunde@emory.edu</email></corresp><fn id="fn1"><label>3</label><p id="ntpara0010">Present address: iMotions, Inc., Boston, MA 02114, USA</p></fn></author-notes><pub-date pub-type="pmc-release"><day>13</day><month>8</month><year>2022</year></pub-date><!-- PMC Release delay is 0 months and 0 days and was based on <pub-date
						pub-type="epub">.--><pub-date pub-type="collection"><day>16</day><month>9</month><year>2022</year></pub-date><pub-date pub-type="epub"><day>13</day><month>8</month><year>2022</year></pub-date><volume>25</volume><issue>9</issue><elocation-id>104920</elocation-id><permissions><copyright-statement>&#x000a9; 2022 The Author(s)</copyright-statement><copyright-year>2022</copyright-year><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbyncndlicense">https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref><license-p>This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).</license-p></license></permissions><abstract id="abs0010"><title>Summary</title><p>The human brain consumes five orders of magnitude more energy than the sun by unit of mass and time. This staggering bioenergetic cost serves mostly synaptic transmission and actin cytoskeleton dynamics. The peak of both brain bioenergetic demands and the age of onset for neurodevelopmental disorders is approximately 5 years of age. This correlation suggests that defects in the machinery that provides cellular energy would be causative and/or consequence of neurodevelopmental disorders. We explore this hypothesis from the perspective of the machinery required for the synthesis of the electron transport chain, an ATP-producing and NADH-consuming enzymatic cascade. The electron transport chain is constituted by nuclear- and mitochondrial-genome-encoded subunits. These subunits are synthesized by the 80S and the 55S ribosomes, which are segregated to the cytoplasm and the mitochondrial matrix, correspondingly. Mitochondrial protein synthesis by the 55S ribosome is the rate-limiting step in the synthesis of electron transport chain components, suggesting that mitochondrial protein synthesis is a bottleneck for tissues with high bionergetic demands. We discuss genetic defects in the human nuclear and mitochondrial genomes that affect these protein synthesis machineries and cause a phenotypic spectrum spanning autism spectrum disorders to neurodegeneration during neurodevelopment. We propose that dysregulated mitochondrial protein synthesis is a chief, yet understudied, causative mechanism of neurodevelopmental and behavioral disorders.</p></abstract><abstract abstract-type="graphical" id="abs0015"><title>Graphical abstract</title><fig id="undfig1" position="anchor"><graphic xlink:href="fx1"/></fig></abstract><abstract abstract-type="teaser" id="abs0020"><p>Biological Sciences, Neuroscience, Cell Biology</p></abstract><kwd-group id="kwrds0010"><title>Subject areas</title><kwd>Biological Sciences</kwd><kwd>Neuroscience</kwd><kwd>Cell Biology</kwd></kwd-group></article-meta></front><body><sec id="sec1"><title>Introduction</title><p id="p0010">Neurodevelopmental disorders comprise a diverse set of debilitating symptoms, including global developmental delay, autism spectrum disorders, intellectual disability, and communication disorders (<xref rid="bib108" ref-type="bibr">Savatt and Myers, 2021</xref>; <xref rid="bib139" ref-type="bibr">Zablotsky et&#x000a0;al., 2019</xref>). According to the Diagnostic and Statistical Manual of Mental Disorders, these disorders &#x0201c;typically manifest early in development, often before the child enters grade school, and are characterized by developmental deficits that produce impairments of personal, social, academic, or occupational functioning&#x0201d;. Developmental deficits range from specific limitations of learning, defects of executive functions to impairments of social abilities or intelligence (<xref rid="bib6" ref-type="bibr">Association, 2013</xref>). It is estimated that up to 17% of children and teens aged 3&#x02013;17 fulfill the criteria for a neurodevelopmental disorder diagnosis (<xref rid="bib108" ref-type="bibr">Savatt and Myers, 2021</xref>; <xref rid="bib139" ref-type="bibr">Zablotsky et&#x000a0;al., 2019</xref>). Other childhood disorders such as schizophrenia are also considered as a disorder of neurodevelopment and affect 1 in 40,000 of children under age 13 (<xref rid="bib45" ref-type="bibr">Gochman et&#x000a0;al., 2011</xref>; <xref rid="bib108" ref-type="bibr">Savatt and Myers, 2021</xref>). There are wide psychological, societal, and financial implications of these disorders, yet the underlying cause of the majority of these conditions remains unknown due to their polygenic nature, which creates challenges for proper treatment. In fact, people with neurodevelopmental and other childhood-onset disorders most often receive symptomatic treatment rather than interventions that address the underlying condition. A chief concern for the scientific community is therefore to identify the mechanisms giving rise to neurodevelopmental disorders, such as bioenergetic defects which we discuss here from the perspective of the mitochondrial protein synthesis machinery. To do so, we focus on neurodevelopmental disorders caused by monogenic defects or those associated to chromosomal copy number variations. We argue that the identity of the mutated gene or chromosomal defect offers a way to unravel putative pathogenesis mechanisms that could be shared with polygenic forms of these disorders (<xref rid="bib75" ref-type="bibr">Lee et&#x000a0;al., 2020</xref>).</p><p id="p0015">The energy demands of the human brain are the highest among vertebrate tissues (<xref rid="bib53" ref-type="bibr">Herculano-Houzel, 2011</xref>). These energy requirements are frequently summarized by the common assertion that &#x0201c;the adult brain accounts for 2% of body weight, yet it is estimated to be responsible for 20% of oxygen consumption and 20%&#x02013;25% of glucose utilization&#x0201d; (<xref rid="fig1" ref-type="fig">Figure&#x000a0;1</xref>A) (<xref rid="bib118" ref-type="bibr">Sokoloff, 1999</xref>). Others have described the consumption of oxygen and nutrients in stark terms. Such statements include the calculation that a gram of the human brain consumes as much ATP and oxygen as a gram of muscle during a marathon (<xref rid="fig1" ref-type="fig">Figure&#x000a0;1</xref>A2) (<xref rid="bib7" ref-type="bibr">Attwell and Laughlin, 2001</xref>). At the cellular level, a staggering &#x0223c;50% of this ATP requirement is devoted to supporting synaptic function and actin cytoskeleton dynamics (<xref rid="bib7" ref-type="bibr">Attwell and Laughlin, 2001</xref>; <xref rid="bib13" ref-type="bibr">Bernstein and Bamburg, 2003</xref>; Harris et&#x000a0;al., 2012; <xref rid="bib78" ref-type="bibr">Li and Sheng, 2022</xref>). The most illustrative, yet less known description of brain bioenergetic consumption considers the energy rate density (<xref rid="fig1" ref-type="fig">Figures&#x000a0;1</xref>A3, 1A4, and 1B) (<xref rid="bib23" ref-type="bibr">Chaisson, 2006</xref>). This parameter relates energy consumption with the mass of the structure consuming energy and time. This calculation reveals that the human brain consumes 2.23E+05 erg s-1 g-1 (<xref rid="fig1" ref-type="fig">Figure&#x000a0;1</xref>B) (<xref rid="bib23" ref-type="bibr">Chaisson, 2006</xref>, <xref rid="bib24" ref-type="bibr">2011a</xref>, <xref rid="bib25" ref-type="bibr">2011b</xref>, <xref rid="bib26" ref-type="bibr">2015</xref>). This value is 10-fold higher than the energy density rate of the human body and five-orders of magnitude larger than that of the sun (2.00E+04 erg s-1 g-1 and 2.00E+00 erg s-1 g-1, respectively) (<xref rid="fig1" ref-type="fig">Figure&#x000a0;1</xref>B) (<xref rid="bib23" ref-type="bibr">Chaisson, 2006</xref>). For additional context, the brain energy rate density is equivalent to the emitted energy of a 100W incandescent light bulb in 7.5&#x000a0;ms (<xref rid="fig1" ref-type="fig">Figure&#x000a0;1</xref>A3). To frame these parameters of bioenergetic consumption in a biological context, these organ or organism energy budgets power the production of ATP by the electron transport chain at rate of around 9E+20 molecules per second. This ATP synthesis amounts to &#x0223c;65&#x000a0;kg of ATP synthesized per day under resting conditions (<xref rid="bib102" ref-type="bibr">Rich, 2003</xref>).<fig id="fig1"><label>Figure&#x000a0;1</label><caption><p>Neurodevelopmental bioenergetic cost in health and disease</p><p>(A1) Graphical representation of the bioenergetic cost of an adult brain according to Sokoloff. 20% of oxygen is consumed by 2% of the body weight representing the adult brain weight (<xref rid="bib118" ref-type="bibr">Sokoloff, 1999</xref>). Each dot represents 1%.</p><p>(A2) represents the equivalence between the amount of energy consumed by the brain and a muscle during a marathon proposed by Atwell (<xref rid="bib7" ref-type="bibr">Attwell and Laughlin, 2001</xref>).</p><p>(A3) depicts the equivalence between the consumption of the human brain of 2.23E+05 erg s-1 g-1 reported by Chaisson (<xref rid="bib24" ref-type="bibr">Chaisson, 2011a</xref>, <xref rid="bib25" ref-type="bibr">2011b</xref>, <xref rid="bib26" ref-type="bibr">2015</xref>) and expressed as the energy consumption of a 100&#x000a0;W incandescent light bulb. A 100&#x000a0;W light bulb emits 1000 million ergs of energy per second according to Sten Odenwald. The weight of a light bulb is about 34 g, therefore the energy rate density of a 100&#x000a0;W light bulb is 1E+9 ergs/34g/1s. Thus, we estimate the human brain consumes the equivalent of 7.5&#x000a0;ms of a 100&#x000a0;W bulb energy emission for every second that the brain consumes energy. It takes 2.2&#x000a0;min for a brain to consume what a 100&#x000a0;W bulb emits in less than 1 millisecond.</p><p>(A4) depicts the comparison of energy density rates in brain and the sun as reported by (<xref rid="bib24" ref-type="bibr">Chaisson, 2011a</xref>, <xref rid="bib25" ref-type="bibr">2011b</xref>, <xref rid="bib26" ref-type="bibr">2015</xref>). Note that the sun generates energy at a rate of 2 erg s-1 g-1 (<xref rid="bib24" ref-type="bibr">Chaisson, 2011a</xref>, <xref rid="bib25" ref-type="bibr">2011b</xref>, <xref rid="bib26" ref-type="bibr">2015</xref>). The Chaisson&#x02019;s calculations can be independently derived and verified <italic>de novo</italic> as follow. Sun energy rate density figure can be obtained from the following astrophysical constants: solar luminosity-energy output&#x000a0;= 384.6 septillion watts (3.846E+26&#x000a0;W or 3.846E+33 ergs per second) and a solar mass of 1.989E+33&#x000a0;g (<xref rid="bib50" ref-type="bibr">Groom, 2000</xref>). The adult brain energy rate density figure can be calculated from the following values: Adult brain weight is 1300&#x000a0;g (<xref rid="bib32" ref-type="bibr">Dekaban, 1978</xref>). An adult human brain consumes 1414&#x000a0;kJ/day&#x000a0;= 1.414E+13 ergs/day= 1.6E+8 ergs/s (<xref rid="bib35" ref-type="bibr">Durnin, 1981</xref>).</p><p>(B) Modified graph depicting the calculation of energy density rates across astronomical and biological scales. Data are expressed in ergs and Joules (blue symbols). Data to calculate energy density rates for 1 and 6&#x000a0;month old brains were obtained from reported brain energy expenditures (<xref rid="bib20" ref-type="bibr">Butte, 2005</xref>) and brain weights (<xref rid="bib32" ref-type="bibr">Dekaban, 1978</xref>).</p><p>(C) Relative brain energy consumption normalized to an adult brain (<xref rid="bib49" ref-type="bibr">Goyal et&#x000a0;al., 2014</xref>; <xref rid="bib72" ref-type="bibr">Kuzawa et&#x000a0;al., 2014</xref>; <xref rid="bib124" ref-type="bibr">Steiner, 2019</xref> #13; <xref rid="bib93" ref-type="bibr">Oyarz&#x000e1;bal et&#x000a0;al., 2021</xref>). Brain weight was obtained from Dekeban et&#x000a0;al. (<xref rid="bib32" ref-type="bibr">Dekaban, 1978</xref>). Insert represents the age of onset of neurodevelopmental disorders according to recent metanalysis (<xref rid="bib119" ref-type="bibr">Solmi et&#x000a0;al., 2022</xref>). Note the coincident peaks in energy consumption and the age of onset for neurodevelopmental disorders.</p><p>(D) Venn diagram representing the overlap of all Mitochondrial Central Dogma annotated genes according to MitoCarta 3.0 (<xref rid="bib101" ref-type="bibr">Rath et&#x000a0;al., 2021</xref>) that possess annotated entries in the Human Phenotype Ontology category Neurodevelopmental Abnormality (HP:0012759). This category is defined as &#x0201c;a deviation from normal of the neurological development of a child, which may include any or all of the aspects of the development of personal, social, gross or fine motor, and cognitive abilities&#x0201d;. Mitochondrial Central Dogma annotated genes are enriched 2.1 times above what is expected by chance. p value was calculated with a hypergeometric test.</p><p>(E) Frequency of annotated phenotypes all Mitochondrial Central Dogma annotated genes according to MitoCarta 3.0 (<xref rid="bib101" ref-type="bibr">Rath et&#x000a0;al., 2021</xref>) that possess annotated entries in the whole Human Phenotype Ontology database. Note that 100% of the gene defects are autosomal recessive with high prevalence of neurodevelopmental phenotypes such as intellectual disability and microcephaly.</p></caption><graphic xlink:href="gr1"/></fig></p><p id="p0020">These diverse ways to describe brain energy budgets are subject to developmental regulation (<xref rid="fig1" ref-type="fig">Figure&#x000a0;1</xref>C). During fetal neurodevelopment, the brain relies mostly on aerobic glycolysis yet at birth the brain progressively increases consumption of oxygen and glucose reaching a maximum around age 5 (<xref rid="fig1" ref-type="fig">Figure&#x000a0;1</xref>C) (<xref rid="bib49" ref-type="bibr">Goyal et&#x000a0;al., 2014</xref>; <xref rid="bib72" ref-type="bibr">Kuzawa et&#x000a0;al., 2014</xref>; <xref rid="bib93" ref-type="bibr">Oyarz&#x000e1;bal et&#x000a0;al., 2021</xref>; <xref rid="bib102" ref-type="bibr">Rich, 2003</xref>; <xref rid="bib124" ref-type="bibr">Steiner, 2019</xref>). This peak in oxygen and glucose consumption is approximately 2-fold higher than the consumption of these substrates by the adult brain (<xref rid="fig1" ref-type="fig">Figure&#x000a0;1</xref>C) (<xref rid="bib49" ref-type="bibr">Goyal et&#x000a0;al., 2014</xref>; <xref rid="bib72" ref-type="bibr">Kuzawa et&#x000a0;al., 2014</xref>; <xref rid="bib93" ref-type="bibr">Oyarz&#x000e1;bal et&#x000a0;al., 2021</xref>; <xref rid="bib124" ref-type="bibr">Steiner, 2019</xref>). If the brain has such high demands, then it is reasonable to postulate that childhood neurodevelopment should be a period of heightened susceptibility to defects in the supply of nutrients as well as genetic or environmental perturbations of the electron transport chain, the machinery that produces ATP. This idea of increased susceptibility is supported by the age of onset for neurodevelopmental disorders which stands at 5.5 years (<xref rid="fig1" ref-type="fig">Figure&#x000a0;1</xref>C, insert) (<xref rid="bib119" ref-type="bibr">Solmi et&#x000a0;al., 2022</xref>). This age of onset is similar for autism spectrum disorder, specific phobias, and separation anxiety disorder, and it is close to the age onset for attention deficit/hyperactivity disorder (<xref rid="bib119" ref-type="bibr">Solmi et&#x000a0;al., 2022</xref>). Interestingly, this time frame also matches the brain&#x02019;s peak glutamatergic synapse density and gray matter volume, emphasizing the developmental linkage between energy consumption and brain maturation (<xref rid="bib14" ref-type="bibr">Bethlehem et&#x000a0;al., 2022</xref>; <xref rid="bib15" ref-type="bibr">Birnbaum and Weinberger, 2017</xref>; <xref rid="bib59" ref-type="bibr">Kang et&#x000a0;al., 2011</xref>). In fact, these early years, before 10 years of age, are a period of heightened post-natal neurogenesis as determined by the presence of doublecortin-positive neurons in the human hippocampus (<xref rid="bib66" ref-type="bibr">Knoth et&#x000a0;al., 2010</xref>; <xref rid="bib120" ref-type="bibr">Spalding et&#x000a0;al., 2013</xref>). Transition from neuroprogenitor cells to mature neurons reprograms metabolism from being preponderantly glycolytic to one dominated by mitochondrial respiration (<xref rid="bib10" ref-type="bibr">Beckervordersandforth, 2017</xref>; <xref rid="bib57" ref-type="bibr">Iwata and Vanderhaeghen, 2021</xref>; <xref rid="bib140" ref-type="bibr">Zheng et&#x000a0;al., 2016</xref>). Importantly, this metabolic transition is necessary for neurogenesis (<xref rid="bib3" ref-type="bibr">Almeida and Vieira, 2017</xref>; <xref rid="bib11" ref-type="bibr">Beckervordersandforth et&#x000a0;al., 2017</xref>; <xref rid="bib57" ref-type="bibr">Iwata and Vanderhaeghen, 2021</xref>). These findings support the idea that defects in this glycolysis to mitochondria transition or mitochondria proper likely contribute to the pathogenesis of neurodevelopmental disorders (<xref rid="bib55" ref-type="bibr">Ilieva et&#x000a0;al., 2022</xref>).</p><p id="p0025">Mitochondrial dysfunction has been linked to the origins of neurodevelopmental disorders, such as fragile X syndrome, Rett syndrome, CDKL5 deficiency syndrome, 22q11.2 deletion syndrome, and Down syndrome, in several recent publications (<xref rid="bib46" ref-type="bibr">Gokhale et&#x000a0;al., 2021</xref>; <xref rid="bib51" ref-type="bibr">Gu et&#x000a0;al., 2013</xref>; <xref rid="bib81" ref-type="bibr">Licznerski et&#x000a0;al., 2020</xref>; <xref rid="bib113" ref-type="bibr">Shulyakova et&#x000a0;al., 2017</xref>; <xref rid="bib129" ref-type="bibr">Valenti et&#x000a0;al., 2018</xref>). A common observation across these disorders is impaired activity of the electron transport chain, an enzymatic cascade constituted by 100 subunits assembled into five protein complexes (<xref rid="bib101" ref-type="bibr">Rath et&#x000a0;al., 2021</xref>). However, there has been little consideration of the two protein synthesis machineries necessary for the electron transport chain synthesis and assembly in the context of neurodevelopmental disorders. Here, we focus on nuclear and mitochondrial protein synthesis, represented by two distinct machineries that translate 87 nuclear-encoded transcripts and 13 mitochondrially encoded messages, respectively (<xref rid="bib9" ref-type="bibr">Balsa et&#x000a0;al., 2012</xref>; <xref rid="bib101" ref-type="bibr">Rath et&#x000a0;al., 2021</xref>). One of these synthesis machineries reside in the cytoplasm and is dependent on the 80S ribosome, which is in charge of translating nuclear-encoded mitochondrial proteins (<xref rid="bib107" ref-type="bibr">Saini and Kumar, 2021</xref>). The second machinery requires the 55S ribosome residing in the mitochondrial matrix, which translates 13 polypeptides encoded by the mitochondrial genome (<xref rid="bib39" ref-type="bibr">Ferrari et&#x000a0;al., 2021</xref>; <xref rid="bib71" ref-type="bibr">Kummer and Ban, 2021</xref>). Similar to the 80S ribosome, the 55S ribosome consists of two subunits, the 28S small subunit and the 39S large subunit (<xref rid="bib39" ref-type="bibr">Ferrari et&#x000a0;al., 2021</xref>; <xref rid="bib71" ref-type="bibr">Kummer and Ban, 2021</xref>). Of these two protein synthesis machineries, mitochondrial protein synthesis is the rate-limiting step in the assembly of respiratory complexes (<xref rid="bib16" ref-type="bibr">Bogenhagen and Haley, 2020</xref>).</p><p id="p0030">Recent studies have demonstrated the specific role of mitochondrial protein synthesis machinery in synaptic plasticity under normal and pathological neurodevelopment (<xref rid="bib19" ref-type="bibr">B&#x000fc;low et&#x000a0;al., 2021b</xref>; <xref rid="bib46" ref-type="bibr">Gokhale et&#x000a0;al., 2021</xref>; <xref rid="bib73" ref-type="bibr">Kuzniewska et&#x000a0;al., 2020</xref>; <xref rid="bib121" ref-type="bibr">Spillane et&#x000a0;al., 2013</xref>). For example, abnormal mitochondrial protein synthesis and bioenergetics were shown to be tied to abnormal plasticity in fragile X syndrome (<xref rid="bib19" ref-type="bibr">B&#x000fc;low et&#x000a0;al., 2021b</xref>; <xref rid="bib31" ref-type="bibr">D'Antoni et&#x000a0;al., 2020</xref>; <xref rid="bib73" ref-type="bibr">Kuzniewska et&#x000a0;al., 2020</xref>; <xref rid="bib81" ref-type="bibr">Licznerski et&#x000a0;al., 2020</xref>), a disorder triggered by upregulated protein synthesis in 80S ribosomes (<xref rid="bib103" ref-type="bibr">Richter et&#x000a0;al., 2015</xref>). These studies further validate the idea that abnormal mitochondrial protein synthesis of nuclear-encoded mitochondrial proteins could be causative of synaptic dysfunction in neurodevelopmental disorders. However, an emerging idea is that the protein synthesis machinery within the mitochondrion can also contribute to synapse function and thus to neurodevelopmental disorders (<xref rid="bib33" ref-type="bibr">Devaraju et&#x000a0;al., 2017</xref>; <xref rid="bib46" ref-type="bibr">Gokhale et&#x000a0;al., 2021</xref>). Here, we review and discuss the emerging evidence supporting a role of these two machineries in neurodevelopmental disorders. We will argue that these two mitochondrial protein synthesis processes are impaired in animal models of neurodevelopmental disorders causing synaptic dysfunction (<xref rid="bib73" ref-type="bibr">Kuzniewska et&#x000a0;al., 2020</xref>; <xref rid="bib76" ref-type="bibr">Lesnik et&#x000a0;al., 2015</xref>), and that defective protein synthesis either in the cytoplasm&#x02019;s 80S ribosome or in the mitochondria by the 55S ribosome is capable of triggering phenotypes observed in neurodevelopmental disorders.</p></sec><sec id="sec2"><title>Mitochondrial functions and the mechanisms of mitochondrial protein synthesis</title><p id="p0035">Mitochondria are the central powerhouses of all cells, including neurons. It is estimated that most neuronal energy demands can be attributed to maintenance of the membrane potential and dynamics of the actin cytoskeleton; these two energetic burdens determine the preferential energy needs of the synapse (<xref rid="bib7" ref-type="bibr">Attwell and Laughlin, 2001</xref>; <xref rid="bib13" ref-type="bibr">Bernstein and Bamburg, 2003</xref>; <xref rid="bib52" ref-type="bibr">Harris et&#x000a0;al., 2012</xref>). The field has been dominated by considering mostly ATP-dependent bioenergetic aspects of mitochondria tied to defects in the electron transport chain. However, defects in the electron transport chain are inextricably linked to changes in the inner mitochondrial membrane potential, metabolic coupling, and NADH/NAD+ and FADH/FAD&#x000a0;+ metabolism (<xref rid="bib122" ref-type="bibr">Spinelli and Haigis, 2018</xref>). Any one of these factors can influence multiple aspects of either cellular or mitochondrial metabolism. For example, there are 149 annotated pathways or mechanisms contributed by the 1136 proteins that make up a mitochondrion (<xref rid="bib101" ref-type="bibr">Rath et&#x000a0;al., 2021</xref>). Many of these pathways are modulated by mitochondrial membrane potential or the NADH/NAD&#x000a0;+ ratio and are shared by most cell types. In fact, an elevated tissue NADH/NAD&#x000a0;+ ratio or &#x0201c;NADH-reductive stress&#x0201d; has been hypothesized as one of the major contributors to the pathology of disorders caused by genetic defects affecting the respiratory chain (<xref rid="bib58" ref-type="bibr">Jain et&#x000a0;al., 2016</xref>; <xref rid="bib96" ref-type="bibr">Patgiri et&#x000a0;al., 2020</xref>; <xref rid="bib111" ref-type="bibr">Sharma et&#x000a0;al., 2021</xref>; <xref rid="bib126" ref-type="bibr">Titov et&#x000a0;al., 2016</xref>; <xref rid="bib135" ref-type="bibr">Yang et&#x000a0;al., 2020</xref>). The neuroscience community has been exploring hypotheses related to defects in the electron transport chain by focusing on ATP production, Ca<sup>++</sup> signaling, and reactive oxygen species. But most of the 149 annotated functions that mitochondria perform have remained largely unexplored in the study of neurodevelopmental and neurodegenerative diseases (<xref rid="bib101" ref-type="bibr">Rath et&#x000a0;al., 2021</xref>; <xref rid="bib122" ref-type="bibr">Spinelli and Haigis, 2018</xref>).</p><p id="p0040">Mitochondria are unique as they contain their own genome organized as circular mtDNA encoding 13 unique mitochondrial proteins, 22 tRNAs, and 4 mitochondrially derived peptides that can act as endocrine factors (<xref rid="bib4" ref-type="bibr">Anderson et&#x000a0;al., 1981</xref>; <xref rid="bib64" ref-type="bibr">Kim et&#x000a0;al., 2017</xref>). The mitochondrion has its own translation machinery, which is distinct from the cytoplasmic due to the mitochondrion&#x02019;s bacterial origin. The 13 mitochondrially translated proteins form crucial subunits of the electron transport chain. The electron transport chain generates ATP in a process called oxidative phosphorylation by transferring electrons from NADH and FADH2 to oxygen (<xref rid="bib122" ref-type="bibr">Spinelli and Haigis, 2018</xref>). However, these 13 proteins are not sufficient for proper mitochondrial functioning, and the mitochondrion therefore relies on &#x0223c;1123 proteins encoded by the nucleus (<xref rid="bib101" ref-type="bibr">Rath et&#x000a0;al., 2021</xref>). The synthesis of the mitochondrial DNA-encoded 13 polypeptides is the rate-limiting step in the assembly of respiratory chain complexes (<xref rid="bib16" ref-type="bibr">Bogenhagen and Haley, 2020</xref>). This is an important finding as it emphasizes the idea that mitochondrial protein synthesis is a point of high susceptibility to perturbation. Studies have uncovered two distinct mechanisms through which proteins translated in the cytosol are imported into the mitochondria. It was first discovered that mRNAs are translated in the cytoplasm and subsequently imported into the mitochondria via receptors on the outer mitochondrial membrane named translocase of outer membrane receptors (<xref rid="bib8" ref-type="bibr">Avenda&#x000f1;o-Monsalve et&#x000a0;al., 2020</xref>). This process is aided by different chaperone proteins both within and outside the mitochondrion (<xref rid="bib44" ref-type="bibr">Gautschi et&#x000a0;al., 2001</xref>). More recently, it was demonstrated that some cytoplasmic ribosomes tether directly to the mitochondrial outer membrane, where the proteins are imported into the mitochondrion as they are translated (<xref rid="bib47" ref-type="bibr">Gold et&#x000a0;al., 2017</xref>; <xref rid="bib56" ref-type="bibr">Itoh et&#x000a0;al., 2021</xref>), an observation that was first made in yeast in the 70s (<xref rid="bib61" ref-type="bibr">Kellems et&#x000a0;al., 1975</xref>). It is still unclear how nuclear mRNAs are identified to be targeted to the mitochondrion, but we do know that certain chaperone proteins are necessary in this process (<xref rid="bib44" ref-type="bibr">Gautschi et&#x000a0;al., 2001</xref>; <xref rid="bib138" ref-type="bibr">Zabezhinsky et&#x000a0;al., 2016</xref>). Further work is needed to elucidate why some newly synthesized proteins are translocated into the mitochondrion post-translationally while others are synthesized in 80S ribosomes tethered directly to the mitochondrion during translation leading to co-translational import. Remarkable new research shows how nuclear-encoded mitochondrial proteins are rapidly translated in response to neuronal activity and other stimulation paradigms, despite this highly coordinated process of translation and import (<xref rid="bib73" ref-type="bibr">Kuzniewska et&#x000a0;al., 2020</xref>). Recent studies propose the interesting idea that mitochondria power the protein synthesis necessary for synaptic plasticity and development (<xref rid="bib73" ref-type="bibr">Kuzniewska et&#x000a0;al., 2020</xref>; <xref rid="bib121" ref-type="bibr">Spillane et&#x000a0;al., 2013</xref>) (see discussion below). As we will discuss later, proper mitochondrial protein synthesis is also necessary for intact mitochondrial health. In summary, mitochondrial functions in the neuron depend on a delicate balance of protein synthesis within and outside of the mitochondrion. In this article, we will not cover the details of mitochondrial protein synthesis in-depth, and we kindly direct readers to recent review articles that have covered the intricacies of this topic (<xref rid="bib39" ref-type="bibr">Ferrari et&#x000a0;al., 2021</xref>; <xref rid="bib71" ref-type="bibr">Kummer and Ban, 2021</xref>).</p></sec><sec id="sec3"><title>Synthesis of nuclear-encoded mitochondrial proteins by the 80S ribosome modulates neuronal plasticity</title><p id="p0045">There is a direct relationship between mitochondrial protein synthesis and synaptic function. Kuzniewska et&#x000a0;al. reported activity-induced translation of mitochondrial proteins in the synapse during NMDA-receptor stimulation (<xref rid="bib73" ref-type="bibr">Kuzniewska et&#x000a0;al., 2020</xref>). The proteins were then imported into the mitochondrion and incorporated into its electron transport chain. Such upregulation in protein synthesis resulted in increased mitochondrial respiration and greater synaptic strength. Importantly, the incorporation of proteins into the electron transport chain was impeded by the protein synthesis inhibitor puromycin. In further support of the idea that plasticity of the mitochondrion depends on protein synthesis pathways, the Kaplan laboratory has presented a long line of elegant evidence for local translation and import of nuclear-encoded mitochondrial proteins in the giant squid axon (<xref rid="bib41" ref-type="bibr">Gale et&#x000a0;al., 2018</xref>; <xref rid="bib60" ref-type="bibr">Kar et&#x000a0;al., 2014</xref>). An interesting study observed that local ablation of mitochondria impeded synaptic strengthening and protein synthesis during a chemical long-term potentiation paradigm (<xref rid="bib99" ref-type="bibr">Rangaraju et&#x000a0;al., 2019</xref>). Whether the protein synthesis involved translation outside and/or within the mitochondria is unknown, and clearly more research is needed to uncover how mitochondrial protein synthesis fuel and participates in neuronal plasticity.</p></sec><sec id="sec4"><title>Mitochondrial protein synthesis during brain development &#x02013; an unaddressed topic</title><p id="p0050">Mitochondrial function and shape change significantly during brain development. Upon neuronal differentiation, mitochondria become smaller and rounder, and produce more reactive oxygen species as neurons start relying on oxidative phosphorylation rather than glycolysis for ATP production (<xref rid="bib62" ref-type="bibr">Khacho et&#x000a0;al., 2016</xref>; <xref rid="bib63" ref-type="bibr">Khacho and Slack, 2018</xref>). As the neuron matures, the mitochondria once again elongate, forming interconnected networks throughout dendrites and cell bodies while in axons mitochondria are smaller in size (<xref rid="bib38" ref-type="bibr">Faitg et&#x000a0;al., 2021</xref>). The activity of the electron transport chain determines mitochondrial shape (<xref rid="bib82" ref-type="bibr">Liesa and Shirihai, 2013</xref>; <xref rid="bib88" ref-type="bibr">Mishra and Chan, 2016</xref>). However, we know almost nothing about mitochondrial protein synthesis during brain development. We argue that critical developmental windows may exist during which mitochondrial protein synthesis could impact neurodevelopment. For example, there is a transition during brain development during which the source of ATP changes, with its production occurring primarily through mitochondrial oxidative phosphorylation rather than glycolysis (<xref rid="bib34" ref-type="bibr">Dienel, 2019</xref>; <xref rid="bib49" ref-type="bibr">Goyal et&#x000a0;al., 2014</xref>; <xref rid="bib93" ref-type="bibr">Oyarz&#x000e1;bal et&#x000a0;al., 2021</xref>; <xref rid="bib140" ref-type="bibr">Zheng et&#x000a0;al., 2016</xref>). In fact, during cell growth, there is a corresponding increase in mitochondrial mass which increases the demand on 80S and 55S protein synthesis to support mitochondrial function and morphology. This type of energetic demand is observed during synaptogenesis, synaptic development, and presynaptic plasticity&#x02014;all key events during brain development (<xref rid="bib93" ref-type="bibr">Oyarz&#x000e1;bal et&#x000a0;al., 2021</xref>)&#x02014;and thus may account for the increased energy demand during early years of brain development.</p><p id="p0055">Genetic and molecular evidence suggests that the mitochondrial protein synthesis machinery is neurodevelopmentally regulated and that genetic defects affecting this machinery produce phenotypes commonly observed in neurodevelopmental disorders (<xref rid="bib46" ref-type="bibr">Gokhale et&#x000a0;al., 2021</xref>) (<xref rid="fig2" ref-type="fig">Figure&#x000a0;2</xref>). For this article, we analyzed the representation of gene defects of all mitochondrial genes annotated to the &#x0201c;Mitochondrial Central Dogma&#x0201d; found in the Mitocarta 3.0 database (<xref rid="bib101" ref-type="bibr">Rath et&#x000a0;al., 2021</xref>). The Mitochondrial Central Dogma spans genes required for the replication of the mtDNA to the synthesis of proteins by the mitochondrial ribosome (<xref rid="bib101" ref-type="bibr">Rath et&#x000a0;al., 2021</xref>). This annotated category contains 230 genes. If we query the Human Phenotype Ontology database, a resource of disease-phenotype and gene annotations (<xref rid="bib67" ref-type="bibr">Kohler et&#x000a0;al., 2017</xref>), with these 230 genes, we find that 59 genes are associated with the &#x0201c;Neurodevelopmental Delay&#x0201d; and &#x0201c;Neurodevelopmental Abnormality&#x0201d; annotated phenotypes (HP:0012758 and HP:0012759, <xref rid="fig1" ref-type="fig">Figure&#x000a0;1</xref>D) (<xref rid="bib132" ref-type="bibr">Villagomez et&#x000a0;al., 2019</xref>) representing an enrichment of these genes of &#x0223c;2-fold above what is expected by chance (p&#x000a0;&#x0003c;&#x000a0;8.95E-9, and &#x0003c;7.23E-9, respectively, hypergeometric test, <xref rid="fig1" ref-type="fig">Figure&#x000a0;1</xref>D). The annotated category &#x0201c;Behavioral Abnormality&#x0201d;, which encompasses autism-spectrum-related behaviors (HP:0000708 and HP:0000729), is comprised of 23 genes belonging to the Mitochondrial Central Dogma. If we expand this analysis to consider all Mitocarta 3.0 genes, and not just the Mitochondrial Central Dogma, overlap with either behavioral abnormality or autism-spectrum-related behaviors represents a significant 2-fold enrichment of mitochondrial genes associated with these phenotypes. Lastly, if we ask how many of the Mitochondrial Central Dogma 230 genes have entries in the Human Phenotype Ontology database, we find 73 genes (<xref rid="fig1" ref-type="fig">Figure&#x000a0;1</xref>E). Analysis of all annotated phenotypes linked to gene defects in these 73 Mitochondrial Central Dogma genes reveals that the most frequent phenotypes are neurodevelopmental phenotypes such as global developmental delay, intellectual disability, and microcephaly (HP:0001263- 0001249- 0000252, <xref rid="fig1" ref-type="fig">Figure&#x000a0;1</xref>E). Gene expression studies of the developing human brain also shed light on the neurodevelopmental regulation of Mitochondrial Central Dogma gene expression. We have previously documented that the expression of mitochondrial ribosome genes is regulated differentially across brain development, brain regions, and neuronal cell types (<xref rid="bib46" ref-type="bibr">Gokhale et&#x000a0;al., 2021</xref>). We used the EvoDevo human RNAseq datasets that explore the expression of genes across the human brain lifespan in diverse organs (<xref rid="bib22" ref-type="bibr">Cardoso-Moreira et&#x000a0;al., 2019</xref>) (<xref rid="fig2" ref-type="fig">Figure&#x000a0;2</xref>). We analyzed the expression of the 230 Mitochondrial Central Dogma annotated genes by reducing the expression of all these genes to their three principal components by principal component analysis (<xref rid="fig2" ref-type="fig">Figure&#x000a0;2</xref>). The expression of these 230 genes shows that there are two clearly distinguishable patterns of Mitochondrial Central Dogma gene expression whose boundary is marked by birth (see <xref rid="fig2" ref-type="fig">Figure&#x000a0;2</xref>B red symbols). Among these genes, all those belonging to subunits of the mitochondrial ribosome and mitochondrial translation factors expressed at the highest levels after birth. These changes in expression are unlikely to result just from increases in mitochondria numbers as the expression of genes required for DNA replication and maintenance, such as TFAM, is at the highest level before birth, in particular under 20&#x000a0;weeks of <italic>in utero</italic> age (<xref rid="fig2" ref-type="fig">Figure&#x000a0;2</xref>B). These findings provide circumstantial evidence in support of mitochondrial protein synthesis as a mechanism contributing to the complex pathology in neurodevelopmental disorders.<fig id="fig2"><label>Figure&#x000a0;2</label><caption><p>Expression profile of Mitochondrial Central Dogma Annotated Genes</p><p>(A) Euclidean distance hierarchical clustering of the mRNA expression of all Mitochondrial Central Dogma annotated genes according to MitoCarta 3.0. Expression data span from 4&#x000a0;weeks post-conception to 55 years of age (<xref rid="bib101" ref-type="bibr">Rath et&#x000a0;al., 2021</xref>). RNAseq data were obtained from EvoDevo human RNAseq datasets (<xref rid="bib22" ref-type="bibr">Cardoso-Moreira et&#x000a0;al., 2019</xref>). High expression is denoted by yellow color. Note the increased expression of mitochondrial ribosome subunit genes (red marks) is increased right after birth.</p><p>(B) Principal component analysis of the data in A. Spheres represent columns in A with the same color code for age. Each PCA graph is superimposed with a heatmap of age (same as in A) or a heatmap of the integrate expression of Mitochondrial Central Dogma subcategories such as mitochondrial ribosome (Mt-Ribosome) as defined by Rath et&#x000a0;al. (<xref rid="bib101" ref-type="bibr">Rath et&#x000a0;al., 2021</xref>). Note that mitochondrial ribosome subunits and components of the mitochondrial DNA replication machinery have peak expression at the ends of the lifespan analyzed.</p></caption><graphic xlink:href="gr2"/></fig></p></sec><sec id="sec5"><title>Causes of mitochondrial protein synthesis dysregulation in neurodevelopmental disorders</title><p id="p0060">Here, we outline distinct mechanisms that can cause mitochondrial protein synthesis dysregulation. Given the focus of the current article, we will provide mechanistic examples from human genetic studies where neurodevelopmental to later-onset phenotypes have been reported associated to a mutation (see for example (<xref rid="bib40" ref-type="bibr">Franco-Iborra et&#x000a0;al., 2018</xref>; <xref rid="bib94" ref-type="bibr">Palmer et&#x000a0;al., 2021</xref>; <xref rid="bib97" ref-type="bibr">Pei and Wallace, 2018</xref>)). We classify these diseases as primary or secondary mitochondrial diseases as defined by <xref rid="bib92" ref-type="bibr">Niyazov et&#x000a0;al. (2016)</xref><underline>.</underline></p><sec id="sec5.1"><title>Primary mitochondrial diseases. Mitochondrial genetic defects directly affecting the mitochondrial protein synthesis machinery</title><p id="p0065">Mutations within the mitochondrial DNA often seriously affect an organism&#x02019;s function and ability to thrive, as each of the 13 nucleoid-encoded proteins and 21 tRNAs are necessary for the integrity of the respiratory chain and mitochondrial respiration (<xref rid="bib127" ref-type="bibr">Tuppen et&#x000a0;al., 2010</xref>; <xref rid="bib133" ref-type="bibr">Wallace, 2018</xref>). However, the symptomology will depend on the number of copies of mutated mitochondrial DNA compared to wild-type copies which can vary across cells and tissues, a phenomenon known as heteroplasmy (<xref rid="bib12" ref-type="bibr">Bernardino Gomes et&#x000a0;al., 2021</xref>). Mitochondrial DNA mutations are typically associated with impaired neurodevelopment, or neurodegeneration after initial normal development (<xref rid="bib105" ref-type="bibr">Ryzhkova et&#x000a0;al., 2018</xref>). These mutations have been mapped to protein-coding RNAs and tRNAs and produce a range of diseases including MELAS syndrome (Mitochondrial Myopathy, Encephalopathy, Lactic Acidosis, and Stroke-Like Episodes, OMIM <ext-link ext-link-type="omim" xlink:href="540000" id="intref0010">540000</ext-link>), Leigh syndrome (OMIM <ext-link ext-link-type="omim" xlink:href="256000" id="intref0015">256000</ext-link>), Leber hereditary optic neuropathy (LHON, OMIM <ext-link ext-link-type="omim" xlink:href="535000" id="intref0020">535000</ext-link>), myoclonic epilepsy with ragged red fibers (MERRF, OMIM <ext-link ext-link-type="omim" xlink:href="545000" id="intref0025">545000</ext-link>), and neuropathy, ataxia, and retinitis pigmentosa syndrome (NARP OMIM <ext-link ext-link-type="omim" xlink:href="551500" id="intref0030">551500</ext-link>). In general, these subjects experience seizures and sensory loss, such as vision and hearing impairment. Issues in the peripheral nervous system are also common although these typically have a later onset (<xref rid="bib109" ref-type="bibr">Schubert Baldo and Vilarinho, 2020</xref>).</p><p id="p0070">We will expand on one example of such diseases caused by mutations in mitochondrial DNA: Leigh syndrome (<xref rid="bib109" ref-type="bibr">Schubert Baldo and Vilarinho, 2020</xref>). Leigh syndrome is a rare genetic disorder affecting brain development and function as well as motor development. Leigh syndrome onset depends on the mutation and degree of heteroplasmy, varying from onset in a few months after birth until adolescence. A frequent mtDNA mutation causing Leigh syndrome is found in the MT-ATP6 gene (<xref rid="bib91" ref-type="bibr">Ng et&#x000a0;al., 2019</xref>), which encodes a subunit of the F0 sector of Complex V in the respiratory chain. This defect impairs the last step of oxidative phosphorylation and significantly reduces ATP production. Such a defect in ATP production is particularly deleterious to cells with high energy demands, such as neurons, which likely accounts for why neurological defects are some of the first symptoms to be observed in people with Leigh syndrome. Symptoms in Leigh syndrome worsen as the load of mutated genomes, or heteroplasmy, increases over time.</p><p id="p0075">An emerging principle is that severe diseases are observed in cases where there is a high degree of heteroplasmy in which the mutated mitochondrial genome predominates (<xref rid="bib133" ref-type="bibr">Wallace, 2018</xref>). However, the same mutation can be associated with different clinical manifestations in a continuum spectrum of disease severity and symptomology. For example, autism spectrum disorders have been associated with low heteroplasmy of a mutation affecting the mitochondrial tRNA for leucine (3243A&#x0003e;G mutation) (<xref rid="bib98" ref-type="bibr">Pons et&#x000a0;al., 2004</xref>; <xref rid="bib136" ref-type="bibr">Yardeni et&#x000a0;al., 2021</xref>). There is an association of type II diabetes and autism with this mutation at heteroplasmy levels between 1/5 and 1/3 of the affected genomes (<xref rid="bib98" ref-type="bibr">Pons et&#x000a0;al., 2004</xref>; <xref rid="bib130" ref-type="bibr">van den Ouweland et&#x000a0;al., 1992</xref>; <xref rid="bib136" ref-type="bibr">Yardeni et&#x000a0;al., 2021</xref>). However, when this mutation is present in more than half of all the mitochondrial genomes in a cell, this mutation associates with MELAS or childhood lethality (<xref rid="bib48" ref-type="bibr">Goto et&#x000a0;al., 1990</xref>). Importantly, these differences in the degree of heteroplasmy have been attributed to differential nuclear gene expression in cells <italic>in&#x000a0;vitro</italic> caused by NADH/NAD&#x000a0;+ cellular metabolism (<xref rid="bib69" ref-type="bibr">Kopinski et&#x000a0;al., 2019</xref>) and electrophysiological phenotypes in iPSC-derived neurons (<xref rid="bib65" ref-type="bibr">Klein Gunnewiek et&#x000a0;al., 2020</xref>).</p></sec><sec id="sec5.2"><title>Primary mitochondrial diseases. Nuclear genetic defects directly affecting the mitochondrial protein synthesis machinery</title><p id="p0080">Mutations in mitochondrial translation factors are causative of severe neurodevelopmental disorders characterized by childhood-onset ataxia and fatal encephalopathy (<xref rid="bib37" ref-type="bibr">Emperador et&#x000a0;al., 2016</xref>; <xref rid="bib128" ref-type="bibr">Valente et&#x000a0;al., 2007</xref>). Similarly, mutations in mitochondrial ribosome proteins comprise a large group of rare neurodevelopmental disorders referred to as &#x0201c;Combined Phosphorylation Deficiency Disorders&#x0201d;, or (COXPD). COXPDs are characterized by reduced activity in electron transport chain complexes and reduced mitochondrial protein synthesis (<xref rid="bib74" ref-type="bibr">Lake et&#x000a0;al., 2017</xref>; <xref rid="bib110" ref-type="bibr">Serre et&#x000a0;al., 2013</xref>; <xref rid="bib116" ref-type="bibr">Smits et&#x000a0;al., 2011</xref>). COXPD subjects vary widely in seriousness and symptom presentation depending on the mutation, some of which can lead to infant death (<xref rid="bib87" ref-type="bibr">Miller et&#x000a0;al., 2004</xref>; <xref rid="bib106" ref-type="bibr">Saada et&#x000a0;al., 2007</xref>), while less severe cases experience delayed psychomotor development, seizures, intellectual disability, and impaired speech and hearing (<xref rid="bib43" ref-type="bibr">Gardeitchik et&#x000a0;al., 2018</xref>; <xref rid="bib74" ref-type="bibr">Lake et&#x000a0;al., 2017</xref>; <xref rid="bib110" ref-type="bibr">Serre et&#x000a0;al., 2013</xref>; <xref rid="bib116" ref-type="bibr">Smits et&#x000a0;al., 2011</xref>). COXPDs can affect the brain, typically observed as abnormal volume and structure of corpus callosum and basal ganglia, as well as reduced myelination. Interestingly, some affected subjects display no anatomical anomalies with brain imaging, despite experiencing significant cognitive symptomology (e.g. intellectual disability) and major metabolic differences, such as increased lactate and reduced oxidative phosphorylation (<xref rid="bib43" ref-type="bibr">Gardeitchik et&#x000a0;al., 2018</xref>). Much like the case of mitochondrial genome mutations, the severity of a genetic defect in mitochondrial ribosome subunits tunes the neurological and neurodevelopmental manifestations. This is suggested by mouse models where a point mutation in MRPS5 that causes mito-ribosomal mistranslation causes a series of endophenotypes associated with neurodevelopmental disorders such as alterations in open field and exploratory activity (<xref rid="bib1" ref-type="bibr">Akbergenov et&#x000a0;al., 2018</xref>; <xref rid="bib112" ref-type="bibr">Shcherbakov et&#x000a0;al., 2021</xref>).</p><p id="p0085">The mitochondrial DNA encodes 21 tRNAs that are loaded with their cognate amino acids by a group of nuclear-encoded aminoacyl-tRNA synthetases (<xref rid="bib68" ref-type="bibr">Konovalova and Tyynismaa, 2013</xref>; <xref rid="bib114" ref-type="bibr">Sissler et&#x000a0;al., 2017</xref>). Amino acid-loaded tRNAs are essential for mitochondrial protein synthesis. Mutations in some of these 19 aminoacyl-tRNA synthetases are associated with systemic and neurological phenotypes that include intellectual disability, epilepsy, and psychomotor defects in children and adults (<xref rid="bib2" ref-type="bibr">Almalki et&#x000a0;al., 2014</xref>; <xref rid="bib27" ref-type="bibr">Ciara et&#x000a0;al., 2018</xref>; <xref rid="bib68" ref-type="bibr">Konovalova and Tyynismaa, 2013</xref>; <xref rid="bib70" ref-type="bibr">Kosaki et&#x000a0;al., 2018</xref>; <xref rid="bib90" ref-type="bibr">Musante et&#x000a0;al., 2017</xref>; <xref rid="bib114" ref-type="bibr">Sissler et&#x000a0;al., 2017</xref>; <xref rid="bib125" ref-type="bibr">Talim et&#x000a0;al., 2013</xref>; <xref rid="bib131" ref-type="bibr">Vantroys et&#x000a0;al., 2017</xref>). These mutations are associated with reduced translation of mitochondrial genes and consequently impaired activity in some or all of the mitochondrial respiratory complexes (<xref rid="bib2" ref-type="bibr">Almalki et&#x000a0;al., 2014</xref>; <xref rid="bib27" ref-type="bibr">Ciara et&#x000a0;al., 2018</xref>; <xref rid="bib70" ref-type="bibr">Kosaki et&#x000a0;al., 2018</xref>; <xref rid="bib90" ref-type="bibr">Musante et&#x000a0;al., 2017</xref>; <xref rid="bib125" ref-type="bibr">Talim et&#x000a0;al., 2013</xref>; <xref rid="bib131" ref-type="bibr">Vantroys et&#x000a0;al., 2017</xref>). Multiple brain areas are affected, in particular, the cerebellum and corpus callosum are affected by these mutations (<xref rid="bib123" ref-type="bibr">Steenweg et&#x000a0;al., 2012</xref>; <xref rid="bib137" ref-type="bibr">Yin et&#x000a0;al., 2018</xref>). For example, pontocerebellar hypoplasia is caused by a mutation in the mitochondrial arginyl-tRNA synthease 2 (RARS2) gene and comprises a heterogeneous group of disorders characterized by severe developmental delay, small cerebellum, and reduced electron transport chain activity (<xref rid="bib36" ref-type="bibr">Edvardson et&#x000a0;al., 2007</xref>; <xref rid="bib80" ref-type="bibr">Li et&#x000a0;al., 2015</xref>; <xref rid="bib100" ref-type="bibr">Rankin et&#x000a0;al., 2010</xref>). Mutations in another mitochondrial tRNA, CARS2, lead to childhood onset epilepsy and delayed psychomotor development, thinning of the corpus callosum and cerebellar atrophy. Like RARS2 mutations, CARS2 mutations also reduce electron transport chain activity in one or more complexes, and even lead to incomplete assembly of some due to translation defects (<xref rid="bib29" ref-type="bibr">Coughlin et&#x000a0;al., 2015</xref>). These&#x000a0;mutations with severe symptoms are part of a spectrum of clinical manifestations that encompass cognitive, behavioral, and movement disorders. Gene defects in WARS2 and AARS2 can cause intellectual disability, psychosis, and early onset movement disorders such as Parkinsonism (<xref rid="bib54" ref-type="bibr">H&#x000fc;bers et&#x000a0;al., 2020</xref>; <xref rid="bib115" ref-type="bibr">Skorvanek et&#x000a0;al., 2022</xref>). In fact, defects in AARS2 cause movement disorders in 71% of cases, cognitive impairment in 67%, and behavioral or psychiatric features in close to half of all the cases so far described (<xref rid="bib95" ref-type="bibr">Parra et&#x000a0;al., 2021</xref>). These pleiotropic behavioral or neurological phenotypes suggest that mitochondrial aminoacyl-tRNA synthetases regulate subtle aspects of neuronal and synapse biology before neurons undergo cell death.</p></sec><sec id="sec5.3"><title>Primary mitochondrial diseases. Nuclear genetic defects indirectly affecting the mitochondrial protein synthesis machinery</title><p id="p0090">Gene defects in nuclear-encoded mitochondrial proteins could indirectly affect the expression of components of the mitochondrial protein synthesis machinery. Gokhale et&#x000a0;al. demonstrated that loss of SLC25A1 (Solute Carrier Family 25 Member 1), a nuclear gene specifying a citrate transporter of the inner mitochondrial membrane, leads to downregulation of multiple mitochondrial ribosome subunits, ultimately impairing mitochondrial translational machinery and subsequent translation of nucleoid-encoded mRNAs (<xref rid="bib46" ref-type="bibr">Gokhale et&#x000a0;al., 2021</xref>). This study also shows that SLC25A1 coprecipitates with mitochondrial ribosomes subunits among these MRPL40 (<xref rid="bib46" ref-type="bibr">Gokhale et&#x000a0;al., 2021</xref>). Impaired expression of mitochondrial ribosome subunits and genetic interactions with SLC25A1 were linked to abnormal synapse development and sleep fragmentation in a <italic>Drosophila</italic> model, two phenotypes that are commonly observed in animal models and human subjects with neurodevelopmental disorders (<xref rid="bib46" ref-type="bibr">Gokhale et&#x000a0;al., 2021</xref>). Gene defects in MRPL40 can cause synaptic defects across multiple species in adults and across neurodevelopmental processes (<xref rid="bib33" ref-type="bibr">Devaraju et&#x000a0;al., 2017</xref>; <xref rid="bib46" ref-type="bibr">Gokhale et&#x000a0;al., 2021</xref>; <xref rid="bib77" ref-type="bibr">Li et&#x000a0;al., 2019</xref>). The interaction between SLC25A1 and MRPL40 is of great interest as these two genes both reside in the chromosomal segment 22q11.2. Loss of one copy of the 22q11.2 locus causes the 22q11.2 microdeletion syndrome a highly penetrant genetic risk factor for autism spectrum disorders, schizophrenia, intellectual disability, and attention-deficit hyperactivity disorder without neurodegeneration or other overt neuroanatomical manifestations (<xref rid="bib86" ref-type="bibr">McDonald-McGinn et&#x000a0;al., 2015</xref>; <xref rid="bib89" ref-type="bibr">Motahari et&#x000a0;al., 2019</xref>; <xref rid="bib141" ref-type="bibr">Zinkstok et&#x000a0;al., 2019</xref>). The data presented by Gokhale tested the role of SLC25A1 in controlling mitochondrial protein synthesis in null cells leaving untested whether a combined hemideficiency of SLC25A1 and MRPL40 is capable of impairing mitochondrial protein synthesis. If protein synthesis of mitochondrial proteins is indeed compromised in 22q11.2 microdeletion brains, where these two genes are deleted in single copy, it will support the concept that synapse biology is uniquely sensitive to defects in mitochondrial proteins synthesis and the electron transport chain.</p></sec><sec id="sec5.4"><title>Secondary mitochondrial diseases. Abnormal cytoplasmic protein synthesis and/or trafficking machinery affecting translation/import of nuclear-encoded mitochondrial proteins</title><p id="p0095">Several neurodevelopmental disorders are characterized by altered cytoplasmic protein synthesis and trafficking. One of the most well studied is fragile X syndrome (FXS), a neurodevelopmental disorder typically characterized by abnormal protein synthesis, particularly during neuronal plasticity paradigms. FXS is caused by loss of the fragile X mental retardation protein (FMRP) which generically functions to inhibit translation, although it has also been shown that FMRP can activate translation and assist in organelle trafficking in dendrites and axons (<xref rid="bib5" ref-type="bibr">Antar et&#x000a0;al., 2006</xref>; <xref rid="bib103" ref-type="bibr">Richter et&#x000a0;al., 2015</xref>). One recent study identified that loss of FMRP during a plasticity paradigm triggered abnormalities in the mitochondrial proteome (<xref rid="bib19" ref-type="bibr">B&#x000fc;low et&#x000a0;al., 2021b</xref>), which was associated with impaired mitochondrial and neuronal plasticity (<xref rid="bib17" ref-type="bibr">B&#x000fc;low et&#x000a0;al., 2019</xref>, <xref rid="bib18" ref-type="bibr">2021a</xref>). Thus, FMRP, a protein responsible for ensuring protein homeostasis, impacts not just the cytoplasm but also the nuclear-encoded mitochondrial proteome. This may explain why certain drugs, such as metformin, known to upregulate mitochondrial pools benefit animal models of FXS (<xref rid="bib42" ref-type="bibr">Gantois et&#x000a0;al., 2017</xref>). In yeast, cytosolic and mitochondrial protein synthesis is coordinated (<xref rid="bib21" ref-type="bibr">Bykov et&#x000a0;al., 2020</xref>; <xref rid="bib30" ref-type="bibr">Couvillion et&#x000a0;al., 2016</xref>; <xref rid="bib71" ref-type="bibr">Kummer and Ban, 2021</xref>). Thus, FMRP mutations offer a unique model to study how a gain of function of cytoplasmic proteins synthesis of mitochondria-targeted proteins could alter mitochondrial protein synthesis and the assembly of respiratory chain complexes.</p><p id="p0100">Charcot-Marie-Tooth (CMT) 2b syndrome is a rare autosomal disorder described by motor and sensory neuropathy with initial symptoms arising around age 5&#x02013;15. CMT is caused by mutations in the Rab7 gene, which normally is involved in the late endocytic pathway. A recent study uncovered that late endosomes serve as platforms for local protein synthesis of nuclear-coded, mitochondria-targeted proteins. Loss of Rab7 compromised the highly coordinated translation between late endosomes and mitochondria ultimately impairing mitochondrial shape and dynamics (<xref rid="bib28" ref-type="bibr">Cioni et&#x000a0;al., 2019</xref>). It is likely but currently unknown that the mitochondrial proteome is altered in CMT and other Rab7-associated disorders. Thus, mutations that impair local sites of translation of nuclear-encoded mitochondrial proteins have direct effects on mitochondrial function and health, with implications for neurodevelopment.</p></sec><sec id="sec5.5"><title>Summary</title><p id="p0105">We have discussed several scenarios where genetic mutations of genes required for mitochondrial protein synthesis directly and severely impact the electron transport chain leading to neurological and sometimes fatal childhood onset diseases. However, mutations on genes required for mitochondrial protein synthesis exist on a spectrum where less severe defects produce behavioral and neurodevelopmental disorders. This is in line with the idea of mitochondrial threshold effects, a concept coined to address phenotypic variability in mitochondrial diseases (<xref rid="bib104" ref-type="bibr">Rossignol et&#x000a0;al., 2003</xref>). Among the less severe disease are mutations that change the protein synthesis machinery by the 80S and the 55S ribosomes, as observed in neurodevelopmental and mostly behavioral disorders caused by mutations in either mitochondrial aminoacyl-tRNA synthetases, fragile X syndrome, and 22q11.2 microdeletion syndrome. In the case of genetic defects producing behavioral phenotypes in the absence of neuropathology, the defect in the electron transport chain may not be easily detectable under &#x0201c;resting&#x0201d; or &#x0201c;baseline&#x0201d; conditions due to compensatory mechanisms or intraneuronal compartment differences. For example, defects of the electron transport chain could be compensated for through enhanced glycolysis-mediated ATP production or mitochondrial biogenesis (<xref rid="bib142" ref-type="bibr">Li et al, 2021</xref>). The contribution of oxidative phosphorylation and glycolysis may vary depending on the subcellular compartment (cell body, dendrite, or synapse), synapse type (excitatory or inhibitory), synapse functional status, and the developmental stage that a particular synapse is undergoing (<xref rid="bib83" ref-type="bibr">Lucas et&#x000a0;al., 2018</xref>; <xref rid="bib84" ref-type="bibr">Lujan et&#x000a0;al., 2016</xref>, <xref rid="bib85" ref-type="bibr">2021</xref>; <xref rid="bib117" ref-type="bibr">Sobieski et&#x000a0;al., 2017</xref>; <xref rid="bib134" ref-type="bibr">Wynne et&#x000a0;al., 2021</xref>). Identification of such compensatory mechanisms that maintain metabolic homeostasis may aid in the detection of underlying mitochondrial defects. In fact, two of the four studies that have identified cytoplasmic changes to mitochondrial protein synthesis as a potential mechanism for neurodevelopmental disorders, did so during a plasticity paradigm (<xref rid="bib18" ref-type="bibr">B&#x000fc;low et&#x000a0;al., 2021a</xref>, <xref rid="bib19" ref-type="bibr">2021b</xref>; <xref rid="bib73" ref-type="bibr">Kuzniewska et&#x000a0;al., 2020</xref>). Neurons are able to compensate for altered electron transport chain function (<xref rid="bib79" ref-type="bibr">Li et&#x000a0;al., 2020</xref>). Therefore, it is important to consider how each of the mechanisms affecting mitochondrial protein synthesis described above could be compensated before the emergence of phenotypic continuums ranging from behavioral defects to severe neurodegeneration.</p></sec></sec></body><back><ref-list id="cebib0010"><title>References</title><ref id="bib1"><element-citation publication-type="journal" id="sref1"><person-group person-group-type="author"><name><surname>Akbergenov</surname><given-names>R.</given-names></name><name><surname>Duscha</surname><given-names>S.</given-names></name><name><surname>Fritz</surname><given-names>A.-K.</given-names></name><name><surname>Juskeviciene</surname><given-names>R.</given-names></name><name><surname>Oishi</surname><given-names>N.</given-names></name><name><surname>Schmitt</surname><given-names>K.</given-names></name><name><surname>Shcherbakov</surname><given-names>D.</given-names></name><name><surname>Teo</surname><given-names>Y.</given-names></name><name><surname>Boukari</surname><given-names>H.</given-names></name><name><surname>Freihofer</surname><given-names>P.</given-names></name><etal/></person-group><article-title>Mutant MRPS5 affects mitoribosomal accuracy and confers stress-related behavioral alterations</article-title><source>EMBO Rep.</source><volume>19</volume><year>2018</year><fpage>e46193</fpage><pub-id pub-id-type="pmid">30237157</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal" id="sref2"><person-group person-group-type="author"><name><surname>Almalki</surname><given-names>A.</given-names></name><name><surname>Alston</surname><given-names>C.L.</given-names></name><name><surname>Parker</surname><given-names>A.</given-names></name><name><surname>Simonic</surname><given-names>I.</given-names></name><name><surname>Mehta</surname><given-names>S.G.</given-names></name><name><surname>He</surname><given-names>L.</given-names></name><name><surname>Reza</surname><given-names>M.</given-names></name><name><surname>Oliveira</surname><given-names>J.M.A.</given-names></name><name><surname>Lightowlers</surname><given-names>R.N.</given-names></name><name><surname>McFarland</surname><given-names>R.</given-names></name><etal/></person-group><article-title>Mutation of the human mitochondrial phenylalanine-tRNA synthetase causes infantile-onset epilepsy and cytochrome c oxidase deficiency</article-title><source>Biochim. Biophys. Acta</source><volume>1842</volume><year>2014</year><fpage>56</fpage><lpage>64</lpage><pub-id pub-id-type="pmid">24161539</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal" id="sref3"><person-group person-group-type="author"><name><surname>Almeida</surname><given-names>A.S.</given-names></name><name><surname>Vieira</surname><given-names>H.L.A.</given-names></name></person-group><article-title>Role of cell metabolism and mitochondrial function during adult neurogenesis</article-title><source>Neurochem. Res.</source><volume>42</volume><year>2017</year><fpage>1787</fpage><lpage>1794</lpage><pub-id pub-id-type="pmid">28000162</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal" id="sref4"><person-group person-group-type="author"><name><surname>Anderson</surname><given-names>S.</given-names></name><name><surname>Bankier</surname><given-names>A.T.</given-names></name><name><surname>Barrell</surname><given-names>B.G.</given-names></name><name><surname>de Bruijn</surname><given-names>M.H.</given-names></name><name><surname>Coulson</surname><given-names>A.R.</given-names></name><name><surname>Drouin</surname><given-names>J.</given-names></name><name><surname>Eperon</surname><given-names>I.C.</given-names></name><name><surname>Nierlich</surname><given-names>D.P.</given-names></name><name><surname>Roe</surname><given-names>B.A.</given-names></name><name><surname>Sanger</surname><given-names>F.</given-names></name><etal/></person-group><article-title>Sequence and organization of the human mitochondrial genome</article-title><source>Nature</source><volume>290</volume><year>1981</year><fpage>457</fpage><lpage>465</lpage><pub-id pub-id-type="pmid">7219534</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal" id="sref5"><person-group person-group-type="author"><name><surname>Antar</surname><given-names>L.N.</given-names></name><name><surname>Li</surname><given-names>C.</given-names></name><name><surname>Zhang</surname><given-names>H.</given-names></name><name><surname>Carroll</surname><given-names>R.C.</given-names></name><name><surname>Bassell</surname><given-names>G.J.</given-names></name></person-group><article-title>Local functions for FMRP in axon growth cone motility and activity-dependent regulation of filopodia and spine synapses</article-title><source>Mol. Cell. Neurosci.</source><volume>32</volume><year>2006</year><fpage>37</fpage><lpage>48</lpage><pub-id pub-id-type="pmid">16631377</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="book" id="sref6"><person-group person-group-type="author"><name><surname>Association</surname><given-names>A.P.</given-names></name></person-group><part-title>Diagnostic and Statistical Manual of Mental Disorders</part-title><edition>5th ed.</edition><year>2013</year></element-citation></ref><ref id="bib7"><element-citation publication-type="journal" id="sref7"><person-group person-group-type="author"><name><surname>Attwell</surname><given-names>D.</given-names></name><name><surname>Laughlin</surname><given-names>S.B.</given-names></name></person-group><article-title>An energy budget for signaling in the grey matter of the brain</article-title><source>J.&#x000a0;Cereb. Blood Flow Metab.</source><volume>21</volume><year>2001</year><fpage>1133</fpage><lpage>1145</lpage><pub-id pub-id-type="pmid">11598490</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal" id="sref8"><person-group person-group-type="author"><name><surname>Avenda&#x000f1;o-Monsalve</surname><given-names>M.C.</given-names></name><name><surname>Ponce-Rojas</surname><given-names>J.C.</given-names></name><name><surname>Funes</surname><given-names>S.</given-names></name></person-group><article-title>From cytosol to mitochondria: the beginning of a protein journey</article-title><source>Biol. Chem.</source><volume>401</volume><year>2020</year><fpage>645</fpage><lpage>661</lpage><pub-id pub-id-type="pmid">32142476</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal" id="sref9"><person-group person-group-type="author"><name><surname>Balsa</surname><given-names>E.</given-names></name><name><surname>Marco</surname><given-names>R.</given-names></name><name><surname>Perales-Clemente</surname><given-names>E.</given-names></name><name><surname>Szklarczyk</surname><given-names>R.</given-names></name><name><surname>Calvo</surname><given-names>E.</given-names></name><name><surname>Land&#x000e1;zuri</surname><given-names>M.O.</given-names></name><name><surname>Enr&#x000ed;quez</surname><given-names>J.A.</given-names></name></person-group><article-title>NDUFA4 is a subunit of complex IV of the mammalian electron transport chain</article-title><source>Cell Metab.</source><volume>16</volume><year>2012</year><fpage>378</fpage><lpage>386</lpage><pub-id pub-id-type="pmid">22902835</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal" id="sref10"><person-group person-group-type="author"><name><surname>Beckervordersandforth</surname><given-names>R.</given-names></name></person-group><article-title>Mitochondrial metabolism-mediated regulation of adult neurogenesis</article-title><source>Brain Plast.</source><volume>3</volume><year>2017</year><fpage>73</fpage><lpage>87</lpage><pub-id pub-id-type="pmid">29765861</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal" id="sref11"><person-group person-group-type="author"><name><surname>Beckervordersandforth</surname><given-names>R.</given-names></name><name><surname>Ebert</surname><given-names>B.</given-names></name><name><surname>Sch&#x000e4;ffner</surname><given-names>I.</given-names></name><name><surname>Moss</surname><given-names>J.</given-names></name><name><surname>Fiebig</surname><given-names>C.</given-names></name><name><surname>Shin</surname><given-names>J.</given-names></name><name><surname>Moore</surname><given-names>D.L.</given-names></name><name><surname>Ghosh</surname><given-names>L.</given-names></name><name><surname>Trinchero</surname><given-names>M.F.</given-names></name><name><surname>Stockburger</surname><given-names>C.</given-names></name><etal/></person-group><article-title>Role of mitochondrial metabolism in the control of early lineage progression and aging phenotypes in adult hippocampal neurogenesis</article-title><source>Neuron</source><volume>93</volume><year>2017</year><fpage>1518</fpage><lpage>1573</lpage><pub-id pub-id-type="pmid">28334613</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal" id="sref12"><person-group person-group-type="author"><name><surname>Bernardino Gomes</surname><given-names>T.M.</given-names></name><name><surname>Ng</surname><given-names>Y.S.</given-names></name><name><surname>Pickett</surname><given-names>S.J.</given-names></name><name><surname>Turnbull</surname><given-names>D.M.</given-names></name><name><surname>Vincent</surname><given-names>A.E.</given-names></name></person-group><article-title>Mitochondrial DNA disorders: from pathogenic variants to preventing transmission</article-title><source>Hum. Mol. Genet.</source><volume>30</volume><year>2021</year><fpage>R245</fpage><lpage>R253</lpage><pub-id pub-id-type="pmid">34169319</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal" id="sref13"><person-group person-group-type="author"><name><surname>Bernstein</surname><given-names>B.W.</given-names></name><name><surname>Bamburg</surname><given-names>J.R.</given-names></name></person-group><article-title>Actin-ATP hydrolysis is a major energy drain for neurons. The Journal of Neuroscience:</article-title><source>J.&#x000a0;Neurosci.</source><volume>23</volume><year>2003</year><fpage>1</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">12514193</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal" id="sref14"><person-group person-group-type="author"><name><surname>Bethlehem</surname><given-names>R.A.I.</given-names></name><name><surname>Seidlitz</surname><given-names>J.</given-names></name><name><surname>White</surname><given-names>S.R.</given-names></name><name><surname>Vogel</surname><given-names>J.W.</given-names></name><name><surname>Anderson</surname><given-names>K.M.</given-names></name><name><surname>Adamson</surname><given-names>C.</given-names></name><name><surname>Adler</surname><given-names>S.</given-names></name><name><surname>Alexopoulos</surname><given-names>G.S.</given-names></name><name><surname>Anagnostou</surname><given-names>E.</given-names></name><name><surname>Areces-Gonzalez</surname><given-names>A.</given-names></name><etal/></person-group><article-title>Brain charts for the human lifespan</article-title><source>Nature</source><volume>604</volume><year>2022</year><fpage>525</fpage><lpage>533</lpage><pub-id pub-id-type="pmid">35388223</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal" id="sref15"><person-group person-group-type="author"><name><surname>Birnbaum</surname><given-names>R.</given-names></name><name><surname>Weinberger</surname><given-names>D.R.</given-names></name></person-group><article-title>Genetic insights into the neurodevelopmental origins of schizophrenia</article-title><source>Nat. Rev. Neurosci.</source><volume>18</volume><year>2017</year><fpage>727</fpage><lpage>740</lpage><pub-id pub-id-type="pmid">29070826</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal" id="sref16"><person-group person-group-type="author"><name><surname>Bogenhagen</surname><given-names>D.F.</given-names></name><name><surname>Haley</surname><given-names>J.D.</given-names></name></person-group><article-title>Pulse-chase SILAC-based analyses reveal selective oversynthesis and rapid turnover of mitochondrial protein components of respiratory complexes</article-title><source>J.&#x000a0;Biol. Chem.</source><volume>295</volume><year>2020</year><fpage>2544</fpage><lpage>2554</lpage><pub-id pub-id-type="pmid">31974161</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal" id="sref17"><person-group person-group-type="author"><name><surname>B&#x000fc;low</surname><given-names>P.</given-names></name><name><surname>Murphy</surname><given-names>T.J.</given-names></name><name><surname>Bassell</surname><given-names>G.J.</given-names></name><name><surname>Wenner</surname><given-names>P.</given-names></name></person-group><article-title>Homeostatic intrinsic plasticity is functionally altered in Fmr1 KO cortical neurons</article-title><source>Cell Rep.</source><volume>26</volume><year>2019</year><fpage>1378</fpage><lpage>1388.e3</lpage><pub-id pub-id-type="pmid">30726724</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal" id="sref18"><person-group person-group-type="author"><name><surname>B&#x000fc;low</surname><given-names>P.</given-names></name><name><surname>Wenner</surname><given-names>P.A.</given-names></name><name><surname>Faundez</surname><given-names>V.</given-names></name><name><surname>Bassell</surname><given-names>G.J.</given-names></name></person-group><article-title>Mitochondrial structure and polarity in dendrites and the axon initial segment are regulated by homeostatic plasticity and dysregulated in fragile X syndrome</article-title><source>Front. Cell Dev. Biol.</source><volume>9</volume><year>2021</year><fpage>702020</fpage><pub-id pub-id-type="pmid">34350185</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal" id="sref19"><person-group person-group-type="author"><name><surname>B&#x000fc;low</surname><given-names>P.</given-names></name><name><surname>Zlatic</surname><given-names>S.A.</given-names></name><name><surname>Wenner</surname><given-names>P.A.</given-names></name><name><surname>Bassell</surname><given-names>G.J.</given-names></name><name><surname>Faundez</surname><given-names>V.</given-names></name></person-group><article-title>FMRP attenuates activity dependent modifications in the mitochondrial proteome</article-title><source>Mol. Brain</source><volume>14</volume><year>2021</year><fpage>75</fpage><pub-id pub-id-type="pmid">33931071</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal" id="sref20"><person-group person-group-type="author"><name><surname>Butte</surname><given-names>N.F.</given-names></name></person-group><article-title>Energy requirements of infants</article-title><source>Public Health Nutr.</source><volume>8</volume><year>2005</year><fpage>953</fpage><lpage>967</lpage><pub-id pub-id-type="pmid">16277814</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal" id="sref21"><person-group person-group-type="author"><name><surname>Bykov</surname><given-names>Y.S.</given-names></name><name><surname>Rapaport</surname><given-names>D.</given-names></name><name><surname>Herrmann</surname><given-names>J.M.</given-names></name><name><surname>Schuldiner</surname><given-names>M.</given-names></name></person-group><article-title>Cytosolic events in the biogenesis of mitochondrial proteins</article-title><source>Trends Biochem. Sci.</source><volume>45</volume><year>2020</year><fpage>650</fpage><lpage>667</lpage><pub-id pub-id-type="pmid">32409196</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal" id="sref22"><person-group person-group-type="author"><name><surname>Cardoso-Moreira</surname><given-names>M.</given-names></name><name><surname>Halbert</surname><given-names>J.</given-names></name><name><surname>Valloton</surname><given-names>D.</given-names></name><name><surname>Velten</surname><given-names>B.</given-names></name><name><surname>Chen</surname><given-names>C.</given-names></name><name><surname>Shao</surname><given-names>Y.</given-names></name><name><surname>Liechti</surname><given-names>A.</given-names></name><name><surname>Ascen&#x000e7;&#x000e3;o</surname><given-names>K.</given-names></name><name><surname>Rummel</surname><given-names>C.</given-names></name><name><surname>Ovchinnikova</surname><given-names>S.</given-names></name><etal/></person-group><article-title>Gene expression across mammalian organ development</article-title><source>Nature</source><volume>571</volume><year>2019</year><fpage>505</fpage><lpage>509</lpage><pub-id pub-id-type="pmid">31243369</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="book" id="sref23"><person-group person-group-type="author"><name><surname>Chaisson</surname><given-names>E.</given-names></name></person-group><part-title>Epic of Evolution: Seven Ages of the Cosmos</part-title><year>2006</year><publisher-name>Columbia University Press</publisher-name></element-citation></ref><ref id="bib24"><element-citation publication-type="journal" id="sref24"><person-group person-group-type="author"><name><surname>Chaisson</surname><given-names>E.J.</given-names></name></person-group><article-title>Energy rate density as a complexity metric and evolutionary driver</article-title><source>Complexity</source><volume>16</volume><year>2011</year><fpage>27</fpage><lpage>40</lpage></element-citation></ref><ref id="bib25"><element-citation publication-type="journal" id="sref25"><person-group person-group-type="author"><name><surname>Chaisson</surname><given-names>E.J.</given-names></name></person-group><article-title>Energy rate density. II. Probing further a new complexity metric</article-title><source>Complexity</source><volume>17</volume><year>2011</year><fpage>44</fpage><lpage>63</lpage></element-citation></ref><ref id="bib26"><element-citation publication-type="journal" id="sref26"><person-group person-group-type="author"><name><surname>Chaisson</surname><given-names>E.</given-names></name></person-group><article-title>Energy flows in low-entropy complex systems</article-title><source>Entropy</source><volume>17</volume><year>2015</year><fpage>8007</fpage><lpage>8018</lpage></element-citation></ref><ref id="bib27"><element-citation publication-type="journal" id="sref27"><person-group person-group-type="author"><name><surname>Ciara</surname><given-names>E.</given-names></name><name><surname>Rokicki</surname><given-names>D.</given-names></name><name><surname>Lazniewski</surname><given-names>M.</given-names></name><name><surname>Mierzewska</surname><given-names>H.</given-names></name><name><surname>Jurkiewicz</surname><given-names>E.</given-names></name><name><surname>Bekiesi&#x00144;ska-Figatowska</surname><given-names>M.</given-names></name><name><surname>Piekutowska-Abramczuk</surname><given-names>D.</given-names></name><name><surname>Iwanicka-Pronicka</surname><given-names>K.</given-names></name><name><surname>Szyma&#x00144;ska</surname><given-names>E.</given-names></name><name><surname>Stawi&#x00144;ski</surname><given-names>P.</given-names></name><etal/></person-group><article-title>Clinical and molecular characteristics of newly reported mitochondrial disease entity caused by biallelic PARS2 mutations</article-title><source>J.&#x000a0;Hum. Genet.</source><volume>63</volume><year>2018</year><fpage>473</fpage><lpage>485</lpage><pub-id pub-id-type="pmid">29410512</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal" id="sref28"><person-group person-group-type="author"><name><surname>Cioni</surname><given-names>J.-M.</given-names></name><name><surname>Lin</surname><given-names>J.Q.</given-names></name><name><surname>Holtermann</surname><given-names>A.V.</given-names></name><name><surname>Koppers</surname><given-names>M.</given-names></name><name><surname>Jakobs</surname><given-names>M.A.H.</given-names></name><name><surname>Azizi</surname><given-names>A.</given-names></name><name><surname>Turner-Bridger</surname><given-names>B.</given-names></name><name><surname>Shigeoka</surname><given-names>T.</given-names></name><name><surname>Franze</surname><given-names>K.</given-names></name><name><surname>Harris</surname><given-names>W.A.</given-names></name><name><surname>Holt</surname><given-names>C.E.</given-names></name></person-group><article-title>Late endosomes act as mRNA translation platforms and sustain mitochondria in axons</article-title><source>Cell</source><volume>176</volume><year>2019</year><fpage>56</fpage><lpage>72.e15</lpage><pub-id pub-id-type="pmid">30612743</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal" id="sref29"><person-group person-group-type="author"><name><surname>Coughlin</surname><given-names>C.R.</given-names></name><name><surname>Scharer</surname><given-names>G.H.</given-names></name><name><surname>Friederich</surname><given-names>M.W.</given-names></name><name><surname>Yu</surname><given-names>H.-C.</given-names></name><name><surname>Geiger</surname><given-names>E.A.</given-names></name><name><surname>Creadon-Swindell</surname><given-names>G.</given-names></name><name><surname>Collins</surname><given-names>A.E.</given-names></name><name><surname>Vanlander</surname><given-names>A.V.</given-names></name><name><surname>Coster</surname><given-names>R.V.</given-names></name><name><surname>Powell</surname><given-names>C.A.</given-names></name><etal/></person-group><article-title>Mutations in the mitochondrial cysteinyl-tRNA synthase gene, CARS2, lead to a severe epileptic encephalopathy and complex movement disorder</article-title><source>J.&#x000a0;Med. Genet.</source><volume>52</volume><year>2015</year><fpage>532</fpage><lpage>540</lpage><pub-id pub-id-type="pmid">25787132</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal" id="sref30"><person-group person-group-type="author"><name><surname>Couvillion</surname><given-names>M.T.</given-names></name><name><surname>Soto</surname><given-names>I.C.</given-names></name><name><surname>Shipkovenska</surname><given-names>G.</given-names></name><name><surname>Churchman</surname><given-names>L.S.</given-names></name></person-group><article-title>Synchronized mitochondrial and cytosolic translation programs</article-title><source>Nature</source><volume>533</volume><year>2016</year><fpage>499</fpage><lpage>503</lpage><pub-id pub-id-type="pmid">27225121</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal" id="sref31"><person-group person-group-type="author"><name><surname>D'Antoni</surname><given-names>S.</given-names></name><name><surname>de Bari</surname><given-names>L.</given-names></name><name><surname>Valenti</surname><given-names>D.</given-names></name><name><surname>Borro</surname><given-names>M.</given-names></name><name><surname>Bonaccorso</surname><given-names>C.M.</given-names></name><name><surname>Simmaco</surname><given-names>M.</given-names></name><name><surname>Vacca</surname><given-names>R.A.</given-names></name><name><surname>Catania</surname><given-names>M.V.</given-names></name></person-group><article-title>Aberrant mitochondrial bioenergetics in the cerebral cortex of the Fmr1 knockout mouse model of fragile X syndrome</article-title><source>Biol. Chem.</source><volume>401</volume><year>2020</year><fpage>497</fpage><lpage>503</lpage><pub-id pub-id-type="pmid">31702995</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal" id="sref32"><person-group person-group-type="author"><name><surname>Dekaban</surname><given-names>A.S.</given-names></name></person-group><article-title>Changes in brain weights during the span of human life: relation of brain weights to body heights and body weights</article-title><source>Ann. Neurol.</source><volume>4</volume><year>1978</year><fpage>345</fpage><lpage>356</lpage><pub-id pub-id-type="pmid">727739</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal" id="sref33"><person-group person-group-type="author"><name><surname>Devaraju</surname><given-names>P.</given-names></name><name><surname>Yu</surname><given-names>J.</given-names></name><name><surname>Eddins</surname><given-names>D.</given-names></name><name><surname>Mellado-Lagarde</surname><given-names>M.M.</given-names></name><name><surname>Earls</surname><given-names>L.R.</given-names></name><name><surname>Westmoreland</surname><given-names>J.J.</given-names></name><name><surname>Quarato</surname><given-names>G.</given-names></name><name><surname>Green</surname><given-names>D.R.</given-names></name><name><surname>Zakharenko</surname><given-names>S.S.</given-names></name></person-group><article-title>Haploinsufficiency of the 22q11.2 microdeletion gene Mrpl40 disrupts short-term synaptic plasticity and working memory through dysregulation of mitochondrial calcium</article-title><source>Mol. Psychiatry</source><volume>22</volume><year>2017</year><fpage>1313</fpage><lpage>1326</lpage><pub-id pub-id-type="pmid">27184122</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal" id="sref34"><person-group person-group-type="author"><name><surname>Dienel</surname><given-names>G.A.</given-names></name></person-group><article-title>Brain glucose metabolism: integration of energetics with function</article-title><source>Physiol. Rev.</source><volume>99</volume><year>2019</year><fpage>949</fpage><lpage>1045</lpage><pub-id pub-id-type="pmid">30565508</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="book" id="sref35"><person-group person-group-type="author"><name><surname>Durnin</surname><given-names>J.V.G.A.</given-names></name></person-group><part-title>Basal metabolic rate in man, J.F.W.U.E.C. On, and E.a.P. Requirements</part-title><year>1981</year><ext-link ext-link-type="uri" xlink:href="http://www.fao.org/3/M2845E/m2845e00.htm" id="interref0010">http://www.fao.org/3/M2845E/m2845e00.htm</ext-link></element-citation></ref><ref id="bib36"><element-citation publication-type="journal" id="sref36"><person-group person-group-type="author"><name><surname>Edvardson</surname><given-names>S.</given-names></name><name><surname>Shaag</surname><given-names>A.</given-names></name><name><surname>Kolesnikova</surname><given-names>O.</given-names></name><name><surname>Gomori</surname><given-names>J.M.</given-names></name><name><surname>Tarassov</surname><given-names>I.</given-names></name><name><surname>Einbinder</surname><given-names>T.</given-names></name><name><surname>Saada</surname><given-names>A.</given-names></name><name><surname>Elpeleg</surname><given-names>O.</given-names></name></person-group><article-title>Deleterious mutation in the mitochondrial arginyl-transfer RNA synthetase gene is associated with pontocerebellar hypoplasia</article-title><source>Am. J. Hum. Genet.</source><volume>81</volume><year>2007</year><fpage>857</fpage><lpage>862</lpage><pub-id pub-id-type="pmid">17847012</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal" id="sref37"><person-group person-group-type="author"><name><surname>Emperador</surname><given-names>S.</given-names></name><name><surname>Bayona-Bafaluy</surname><given-names>M.P.</given-names></name><name><surname>Fern&#x000e1;ndez-Marmiesse</surname><given-names>A.</given-names></name><name><surname>Pineda</surname><given-names>M.</given-names></name><name><surname>Felgueroso</surname><given-names>B.</given-names></name><name><surname>L&#x000f3;pez-Gallardo</surname><given-names>E.</given-names></name><name><surname>Artuch</surname><given-names>R.</given-names></name><name><surname>Roca</surname><given-names>I.</given-names></name><name><surname>Ruiz-Pesini</surname><given-names>E.</given-names></name><name><surname>Couce</surname><given-names>M.L.</given-names></name><name><surname>Montoya</surname><given-names>J.</given-names></name></person-group><article-title>Molecular-genetic characterization and rescue of a TSFM mutation causing childhood-onset ataxia and nonobstructive cardiomyopathy</article-title><source>Eur. J. Hum. Genet.</source><volume>25</volume><year>2016</year><fpage>153</fpage><lpage>156</lpage><pub-id pub-id-type="pmid">27677415</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal" id="sref38"><person-group person-group-type="author"><name><surname>Faitg</surname><given-names>J.</given-names></name><name><surname>Lacefield</surname><given-names>C.</given-names></name><name><surname>Davey</surname><given-names>T.</given-names></name><name><surname>White</surname><given-names>K.</given-names></name><name><surname>Laws</surname><given-names>R.</given-names></name><name><surname>Kosmidis</surname><given-names>S.</given-names></name><name><surname>Reeve</surname><given-names>A.K.</given-names></name><name><surname>Kandel</surname><given-names>E.R.</given-names></name><name><surname>Vincent</surname><given-names>A.E.</given-names></name><name><surname>Picard</surname><given-names>M.</given-names></name></person-group><article-title>3D neuronal mitochondrial morphology in axons, dendrites, and somata of the aging mouse hippocampus</article-title><source>Cell Rep.</source><volume>36</volume><year>2021</year><fpage>109509</fpage><pub-id pub-id-type="pmid">34380033</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal" id="sref39"><person-group person-group-type="author"><name><surname>Ferrari</surname><given-names>A.</given-names></name><name><surname>Del'Olio</surname><given-names>S.</given-names></name><name><surname>Barrientos</surname><given-names>A.</given-names></name></person-group><article-title>The diseased mitoribosome</article-title><source>FEBS Lett.</source><volume>595</volume><year>2021</year><fpage>1025</fpage><lpage>1061</lpage><pub-id pub-id-type="pmid">33314036</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal" id="sref40"><person-group person-group-type="author"><name><surname>Franco-Iborra</surname><given-names>S.</given-names></name><name><surname>Cuadros</surname><given-names>T.</given-names></name><name><surname>Parent</surname><given-names>A.</given-names></name><name><surname>Romero-Gimenez</surname><given-names>J.</given-names></name><name><surname>Vila</surname><given-names>M.</given-names></name><name><surname>Perier</surname><given-names>C.</given-names></name></person-group><article-title>Defective mitochondrial protein import contributes to complex I-induced mitochondrial dysfunction and neurodegeneration in Parkinson's disease</article-title><source>Cell Death Dis.</source><volume>9</volume><year>2018</year><fpage>1122</fpage><pub-id pub-id-type="pmid">30405116</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal" id="sref41"><person-group person-group-type="author"><name><surname>Gale</surname><given-names>J.R.</given-names></name><name><surname>Aschrafi</surname><given-names>A.</given-names></name><name><surname>Gioio</surname><given-names>A.E.</given-names></name><name><surname>Kaplan</surname><given-names>B.B.</given-names></name></person-group><article-title>Nuclear-encoded mitochondrial mRNAs: a powerful force in axonal growth and development. The neuroscientist: a review journal bringing neurobiology,</article-title><source>Neuroscientist</source><volume>24</volume><year>2018</year><fpage>142</fpage><lpage>155</lpage><pub-id pub-id-type="pmid">28614981</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal" id="sref42"><person-group person-group-type="author"><name><surname>Gantois</surname><given-names>I.</given-names></name><name><surname>Khoutorsky</surname><given-names>A.</given-names></name><name><surname>Popic</surname><given-names>J.</given-names></name><name><surname>Aguilar-Valles</surname><given-names>A.</given-names></name><name><surname>Freemantle</surname><given-names>E.</given-names></name><name><surname>Cao</surname><given-names>R.</given-names></name><name><surname>Sharma</surname><given-names>V.</given-names></name><name><surname>Pooters</surname><given-names>T.</given-names></name><name><surname>Nagpal</surname><given-names>A.</given-names></name><name><surname>Skalecka</surname><given-names>A.</given-names></name><etal/></person-group><article-title>Metformin ameliorates core deficits in a mouse model of fragile X syndrome</article-title><source>Nat. Med.</source><volume>23</volume><year>2017</year><fpage>674</fpage><lpage>677</lpage><pub-id pub-id-type="pmid">28504725</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal" id="sref43"><person-group person-group-type="author"><name><surname>Gardeitchik</surname><given-names>T.</given-names></name><name><surname>Mohamed</surname><given-names>M.</given-names></name><name><surname>Ruzzenente</surname><given-names>B.</given-names></name><name><surname>Karall</surname><given-names>D.</given-names></name><name><surname>Guerrero-Castillo</surname><given-names>S.</given-names></name><name><surname>Dalloyaux</surname><given-names>D.</given-names></name><name><surname>van den Brand</surname><given-names>M.</given-names></name><name><surname>van Kraaij</surname><given-names>S.</given-names></name><name><surname>van Asbeck</surname><given-names>E.</given-names></name><name><surname>Assouline</surname><given-names>Z.</given-names></name><etal/></person-group><article-title>Bi-Allelic mutations in the mitochondrial ribosomal protein MRPS2 cause sensorineural hearing loss, hypoglycemia, and multiple OXPHOS complex deficiencies</article-title><source>Am. J. Hum. Genet.</source><volume>102</volume><year>2018</year><fpage>685</fpage><lpage>695</lpage><pub-id pub-id-type="pmid">29576219</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal" id="sref44"><person-group person-group-type="author"><name><surname>Gautschi</surname><given-names>M.</given-names></name><name><surname>Lilie</surname><given-names>H.</given-names></name><name><surname>F&#x000fc;nfschilling</surname><given-names>U.</given-names></name><name><surname>Mun</surname><given-names>A.</given-names></name><name><surname>Ross</surname><given-names>S.</given-names></name><name><surname>Lithgow</surname><given-names>T.</given-names></name><name><surname>R&#x000fc;cknagel</surname><given-names>P.</given-names></name><name><surname>Rospert</surname><given-names>S.</given-names></name></person-group><article-title>RAC, a stable ribosome-associated complex in yeast formed by the DnaK-DnaJ homologs Ssz1p and zuotin</article-title><source>Proc. Natl. Acad. Sci. USA</source><volume>98</volume><year>2001</year><fpage>3762</fpage><lpage>3767</lpage><pub-id pub-id-type="pmid">11274393</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal" id="sref45"><person-group person-group-type="author"><name><surname>Gochman</surname><given-names>P.</given-names></name><name><surname>Miller</surname><given-names>R.</given-names></name><name><surname>Rapoport</surname><given-names>J.L.</given-names></name></person-group><article-title>Childhood-onset schizophrenia: the challenge of diagnosis</article-title><source>Curr. Psychiatry Rep.</source><volume>13</volume><year>2011</year><fpage>321</fpage><lpage>322</lpage><pub-id pub-id-type="pmid">21713647</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal" id="sref46"><person-group person-group-type="author"><name><surname>Gokhale</surname><given-names>A.</given-names></name><name><surname>Lee</surname><given-names>C.E.</given-names></name><name><surname>Zlatic</surname><given-names>S.A.</given-names></name><name><surname>Freeman</surname><given-names>A.A.H.</given-names></name><name><surname>Shearing</surname><given-names>N.</given-names></name><name><surname>Hartwig</surname><given-names>C.</given-names></name><name><surname>Ogunbona</surname><given-names>O.</given-names></name><name><surname>Bassell</surname><given-names>J.L.</given-names></name><name><surname>Wynne</surname><given-names>M.E.</given-names></name><name><surname>Werner</surname><given-names>E.</given-names></name><etal/></person-group><article-title>Mitochondrial proteostasis requires genes encoded in a neurodevelopmental syndrome locus. The journal of neuroscience:</article-title><source>J.&#x000a0;Neurosci.</source><volume>41</volume><year>2021</year><fpage>6596</fpage><lpage>6616</lpage><pub-id pub-id-type="pmid">34261699</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal" id="sref47"><person-group person-group-type="author"><name><surname>Gold</surname><given-names>V.A.</given-names></name><name><surname>Chroscicki</surname><given-names>P.</given-names></name><name><surname>Bragoszewski</surname><given-names>P.</given-names></name><name><surname>Chacinska</surname><given-names>A.</given-names></name></person-group><article-title>Visualization of cytosolic ribosomes on the surface of mitochondria by electron cryo-tomography</article-title><source>EMBO Rep.</source><volume>18</volume><year>2017</year><fpage>1786</fpage><lpage>1800</lpage><pub-id pub-id-type="pmid">28827470</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal" id="sref48"><person-group person-group-type="author"><name><surname>Goto</surname><given-names>Y.</given-names></name><name><surname>Nonaka</surname><given-names>I.</given-names></name><name><surname>Horai</surname><given-names>S.</given-names></name></person-group><article-title>A mutation in the tRNA(Leu)(UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies</article-title><source>Nature</source><volume>348</volume><year>1990</year><fpage>651</fpage><lpage>653</lpage><pub-id pub-id-type="pmid">2102678</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal" id="sref49"><person-group person-group-type="author"><name><surname>Goyal</surname><given-names>M.S.</given-names></name><name><surname>Hawrylycz</surname><given-names>M.</given-names></name><name><surname>Miller</surname><given-names>J.A.</given-names></name><name><surname>Snyder</surname><given-names>A.Z.</given-names></name><name><surname>Raichle</surname><given-names>M.E.</given-names></name></person-group><article-title>Aerobic glycolysis in the human brain is associated with development and neotenous gene expression</article-title><source>Cell Metab.</source><volume>19</volume><year>2014</year><fpage>49</fpage><lpage>57</lpage><pub-id pub-id-type="pmid">24411938</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal" id="sref50"><person-group person-group-type="author"><name><surname>Groom</surname><given-names>D.E.</given-names></name></person-group><article-title>Astrophysical constants</article-title><source>Eur. Phys. J. C (EPJ C), - Part. Fields</source><volume>15</volume><year>2000</year><fpage>74</fpage><lpage>75</lpage></element-citation></ref><ref id="bib51"><element-citation publication-type="journal" id="sref51"><person-group person-group-type="author"><name><surname>Gu</surname><given-names>F.</given-names></name><name><surname>Chauhan</surname><given-names>V.</given-names></name><name><surname>Kaur</surname><given-names>K.</given-names></name><name><surname>Brown</surname><given-names>W.T.</given-names></name><name><surname>LaFauci</surname><given-names>G.</given-names></name><name><surname>Wegiel</surname><given-names>J.</given-names></name><name><surname>Chauhan</surname><given-names>A.</given-names></name></person-group><article-title>Alterations in mitochondrial DNA copy number and the activities of electron transport chain complexes and pyruvate dehydrogenase in the frontal cortex from subjects with autism</article-title><source>Transl. Psychiatry</source><volume>3</volume><year>2013</year><fpage>e299</fpage><pub-id pub-id-type="pmid">24002085</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal" id="sref52"><person-group person-group-type="author"><name><surname>Harris</surname><given-names>J.J.</given-names></name><name><surname>Jolivet</surname><given-names>R.</given-names></name><name><surname>Attwell</surname><given-names>D.</given-names></name></person-group><article-title>Synaptic energy use and supply</article-title><source>Neuron</source><volume>75</volume><year>2012</year><fpage>762</fpage><lpage>777</lpage><pub-id pub-id-type="pmid">22958818</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal" id="sref53"><person-group person-group-type="author"><name><surname>Herculano-Houzel</surname><given-names>S.</given-names></name></person-group><article-title>Scaling of brain metabolism with a fixed energy budget per neuron: implications for neuronal activity, plasticity and evolution</article-title><source>PLoS One</source><volume>6</volume><year>2011</year><object-id pub-id-type="publisher-id">e17514</object-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal" id="sref54"><person-group person-group-type="author"><name><surname>H&#x000fc;bers</surname><given-names>A.</given-names></name><name><surname>Huppertz</surname><given-names>H.-J.</given-names></name><name><surname>Wortmann</surname><given-names>S.B.</given-names></name><name><surname>Kassubek</surname><given-names>J.</given-names></name></person-group><article-title>Mutation of the WARS2 gene as the cause of a severe hyperkinetic movement disorder</article-title><source>Mov. Disord. Clin. Pract.</source><volume>7</volume><year>2020</year><fpage>88</fpage><lpage>90</lpage><pub-id pub-id-type="pmid">31970218</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal" id="sref55"><person-group person-group-type="author"><name><surname>Ilieva</surname><given-names>M.</given-names></name><name><surname>Aldana</surname><given-names>B.I.</given-names></name><name><surname>Vinten</surname><given-names>K.T.</given-names></name><name><surname>Hohmann</surname><given-names>S.</given-names></name><name><surname>Woofenden</surname><given-names>T.W.</given-names></name><name><surname>Lukjanska</surname><given-names>R.</given-names></name><name><surname>Waagepetersen</surname><given-names>H.S.</given-names></name><name><surname>Michel</surname><given-names>T.M.</given-names></name></person-group><article-title>Proteomic phenotype of cerebral organoids derived from autism spectrum disorder patients reveal disrupted energy metabolism, cellular components, and biological processes</article-title><source>Mol. Psychiatry</source><year>2022</year><pub-id pub-id-type="doi">10.1038/s41380-022-01627-2</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal" id="sref56"><person-group person-group-type="author"><name><surname>Itoh</surname><given-names>Y.</given-names></name><name><surname>Andr&#x000e9;ll</surname><given-names>J.</given-names></name><name><surname>Choi</surname><given-names>A.</given-names></name><name><surname>Richter</surname><given-names>U.</given-names></name><name><surname>Maiti</surname><given-names>P.</given-names></name><name><surname>Best</surname><given-names>R.B.</given-names></name><name><surname>Barrientos</surname><given-names>A.</given-names></name><name><surname>Battersby</surname><given-names>B.J.</given-names></name><name><surname>Amunts</surname><given-names>A.</given-names></name></person-group><article-title>Mechanism of membrane-tethered mitochondrial protein synthesis</article-title><source>Science</source><volume>371</volume><year>2021</year><fpage>846</fpage><lpage>849</lpage><pub-id pub-id-type="pmid">33602856</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal" id="sref57"><person-group person-group-type="author"><name><surname>Iwata</surname><given-names>R.</given-names></name><name><surname>Vanderhaeghen</surname><given-names>P.</given-names></name></person-group><article-title>Regulatory roles of mitochondria and metabolism in neurogenesis</article-title><source>Curr. Opin. Neurobiol.</source><volume>69</volume><year>2021</year><fpage>231</fpage><lpage>240</lpage><pub-id pub-id-type="pmid">34171617</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal" id="sref58"><person-group person-group-type="author"><name><surname>Jain</surname><given-names>I.H.</given-names></name><name><surname>Zazzeron</surname><given-names>L.</given-names></name><name><surname>Goli</surname><given-names>R.</given-names></name><name><surname>Alexa</surname><given-names>K.</given-names></name><name><surname>Schatzman-Bone</surname><given-names>S.</given-names></name><name><surname>Dhillon</surname><given-names>H.</given-names></name><name><surname>Goldberger</surname><given-names>O.</given-names></name><name><surname>Peng</surname><given-names>J.</given-names></name><name><surname>Shalem</surname><given-names>O.</given-names></name><name><surname>Sanjana</surname><given-names>N.E.</given-names></name><etal/></person-group><article-title>Hypoxia as a therapy for mitochondrial disease</article-title><source>Science</source><volume>352</volume><year>2016</year><fpage>54</fpage><lpage>61</lpage><pub-id pub-id-type="pmid">26917594</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal" id="sref59"><person-group person-group-type="author"><name><surname>Kang</surname><given-names>H.J.</given-names></name><name><surname>Kawasawa</surname><given-names>Y.I.</given-names></name><name><surname>Cheng</surname><given-names>F.</given-names></name><name><surname>Zhu</surname><given-names>Y.</given-names></name><name><surname>Xu</surname><given-names>X.</given-names></name><name><surname>Li</surname><given-names>M.</given-names></name><name><surname>Sousa</surname><given-names>A.M.M.</given-names></name><name><surname>Pletikos</surname><given-names>M.</given-names></name><name><surname>Meyer</surname><given-names>K.A.</given-names></name><name><surname>Sedmak</surname><given-names>G.</given-names></name><etal/></person-group><article-title>Spatio-temporal transcriptome of the human brain</article-title><source>Nature</source><volume>478</volume><year>2011</year><fpage>483</fpage><lpage>489</lpage><pub-id pub-id-type="pmid">22031440</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal" id="sref60"><person-group person-group-type="author"><name><surname>Kar</surname><given-names>A.N.</given-names></name><name><surname>Sun</surname><given-names>C.-Y.</given-names></name><name><surname>Reichard</surname><given-names>K.</given-names></name><name><surname>Gervasi</surname><given-names>N.M.</given-names></name><name><surname>Pickel</surname><given-names>J.</given-names></name><name><surname>Nakazawa</surname><given-names>K.</given-names></name><name><surname>Gioio</surname><given-names>A.E.</given-names></name><name><surname>Kaplan</surname><given-names>B.B.</given-names></name></person-group><article-title>Dysregulation of the axonal trafficking of nuclear-encoded mitochondrial mRNA alters neuronal mitochondrial activity and mouse behavior</article-title><source>Dev. Neurobiol.</source><volume>74</volume><year>2014</year><fpage>333</fpage><lpage>350</lpage><pub-id pub-id-type="pmid">24151253</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal" id="sref61"><person-group person-group-type="author"><name><surname>Kellems</surname><given-names>R.E.</given-names></name><name><surname>Allison</surname><given-names>V.F.</given-names></name><name><surname>Butow</surname><given-names>R.A.</given-names></name></person-group><article-title>Cytoplasmic type 80S ribosomes associated with yeast mitochondria. IV. Attachment of ribosomes to the outer membrane of isolated mitochondria</article-title><source>J.&#x000a0;Cell Biol.</source><volume>65</volume><year>1975</year><fpage>1</fpage><lpage>14</lpage><pub-id pub-id-type="pmid">1092698</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal" id="sref62"><person-group person-group-type="author"><name><surname>Khacho</surname><given-names>M.</given-names></name><name><surname>Clark</surname><given-names>A.</given-names></name><name><surname>Svoboda</surname><given-names>D.S.</given-names></name><name><surname>Azzi</surname><given-names>J.</given-names></name><name><surname>MacLaurin</surname><given-names>J.G.</given-names></name><name><surname>Meghaizel</surname><given-names>C.</given-names></name><name><surname>Sesaki</surname><given-names>H.</given-names></name><name><surname>Lagace</surname><given-names>D.C.</given-names></name><name><surname>Germain</surname><given-names>M.</given-names></name><name><surname>Harper</surname><given-names>M.-E.</given-names></name><etal/></person-group><article-title>Mitochondrial dynamics impacts stem cell identity and fate decisions by regulating a nuclear transcriptional program</article-title><source>Cell Stem Cell</source><volume>19</volume><year>2016</year><fpage>232</fpage><lpage>247</lpage><pub-id pub-id-type="pmid">27237737</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal" id="sref63"><person-group person-group-type="author"><name><surname>Khacho</surname><given-names>M.</given-names></name><name><surname>Slack</surname><given-names>R.S.</given-names></name></person-group><article-title>Mitochondrial dynamics in the regulation of neurogenesis: from development to the adult brain</article-title><source>Dev. Dyn.</source><volume>247</volume><year>2018</year><fpage>47</fpage><lpage>53</lpage><pub-id pub-id-type="pmid">28643345</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal" id="sref64"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>S.-J.</given-names></name><name><surname>Xiao</surname><given-names>J.</given-names></name><name><surname>Wan</surname><given-names>J.</given-names></name><name><surname>Cohen</surname><given-names>P.</given-names></name><name><surname>Yen</surname><given-names>K.</given-names></name></person-group><article-title>Mitochondrially derived peptides as novel regulators of metabolism</article-title><source>J.&#x000a0;Physiol.</source><volume>595</volume><year>2017</year><fpage>6613</fpage><lpage>6621</lpage><pub-id pub-id-type="pmid">28574175</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal" id="sref65"><person-group person-group-type="author"><name><surname>Klein Gunnewiek</surname><given-names>T.M.</given-names></name><name><surname>Van Hugte</surname><given-names>E.J.H.</given-names></name><name><surname>Frega</surname><given-names>M.</given-names></name><name><surname>Guardia</surname><given-names>G.S.</given-names></name><name><surname>Foreman</surname><given-names>K.</given-names></name><name><surname>Panneman</surname><given-names>D.</given-names></name><name><surname>Mossink</surname><given-names>B.</given-names></name><name><surname>Linda</surname><given-names>K.</given-names></name><name><surname>Keller</surname><given-names>J.M.</given-names></name><name><surname>Schubert</surname><given-names>D.</given-names></name><etal/></person-group><article-title>m.3243A&#x000a0;&#x0003e;&#x000a0;G-induced mitochondrial dysfunction impairs human neuronal development and reduces neuronal network activity and synchronicity</article-title><source>Cell Rep.</source><volume>31</volume><year>2020</year><object-id pub-id-type="publisher-id">107538</object-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal" id="sref66"><person-group person-group-type="author"><name><surname>Knoth</surname><given-names>R.</given-names></name><name><surname>Singec</surname><given-names>I.</given-names></name><name><surname>Ditter</surname><given-names>M.</given-names></name><name><surname>Pantazis</surname><given-names>G.</given-names></name><name><surname>Capetian</surname><given-names>P.</given-names></name><name><surname>Meyer</surname><given-names>R.P.</given-names></name><name><surname>Horvat</surname><given-names>V.</given-names></name><name><surname>Volk</surname><given-names>B.</given-names></name><name><surname>Kempermann</surname><given-names>G.</given-names></name></person-group><article-title>Murine features of neurogenesis in the human hippocampus across the lifespan from 0 to 100 years</article-title><source>PLoS One</source><volume>5</volume><year>2010</year><object-id pub-id-type="publisher-id">e8809</object-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal" id="sref67"><person-group person-group-type="author"><name><surname>K&#x000f6;hler</surname><given-names>S.</given-names></name><name><surname>Vasilevsky</surname><given-names>N.A.</given-names></name><name><surname>Engelstad</surname><given-names>M.</given-names></name><name><surname>Foster</surname><given-names>E.</given-names></name><name><surname>McMurry</surname><given-names>J.</given-names></name><name><surname>Aym&#x000e9;</surname><given-names>S.</given-names></name><name><surname>Baynam</surname><given-names>G.</given-names></name><name><surname>Bello</surname><given-names>S.M.</given-names></name><name><surname>Boerkoel</surname><given-names>C.F.</given-names></name><name><surname>Boycott</surname><given-names>K.M.</given-names></name><etal/></person-group><article-title>The human phenotype ontology in 2017</article-title><source>Nucleic Acids Res.</source><volume>45</volume><year>2017</year><fpage>D865</fpage><lpage>D876</lpage><pub-id pub-id-type="pmid">27899602</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal" id="sref68"><person-group person-group-type="author"><name><surname>Konovalova</surname><given-names>S.</given-names></name><name><surname>Tyynismaa</surname><given-names>H.</given-names></name></person-group><article-title>Mitochondrial aminoacyl-tRNA synthetases in human disease</article-title><source>Mol. Genet. Metabol.</source><volume>108</volume><year>2013</year><fpage>206</fpage><lpage>211</lpage></element-citation></ref><ref id="bib69"><element-citation publication-type="journal" id="sref69"><person-group person-group-type="author"><name><surname>Kopinski</surname><given-names>P.K.</given-names></name><name><surname>Janssen</surname><given-names>K.A.</given-names></name><name><surname>Schaefer</surname><given-names>P.M.</given-names></name><name><surname>Trefely</surname><given-names>S.</given-names></name><name><surname>Perry</surname><given-names>C.E.</given-names></name><name><surname>Potluri</surname><given-names>P.</given-names></name><name><surname>Tintos-Hernandez</surname><given-names>J.A.</given-names></name><name><surname>Singh</surname><given-names>L.N.</given-names></name><name><surname>Karch</surname><given-names>K.R.</given-names></name><name><surname>Campbell</surname><given-names>S.L.</given-names></name><etal/></person-group><article-title>Regulation of nuclear epigenome by mitochondrial DNA heteroplasmy</article-title><source>Proc. Natl. Acad. Sci. USA</source><volume>116</volume><year>2019</year><fpage>16028</fpage><lpage>16035</lpage><pub-id pub-id-type="pmid">31253706</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal" id="sref70"><person-group person-group-type="author"><name><surname>Kosaki</surname><given-names>R.</given-names></name><name><surname>Horikawa</surname><given-names>R.</given-names></name><name><surname>Fujii</surname><given-names>E.</given-names></name><name><surname>Kosaki</surname><given-names>K.</given-names></name></person-group><article-title>Biallelic mutations in LARS2 can cause Perrault syndrome type 2 with neurologic symptoms</article-title><source>Am. J. Med. Genet.</source><volume>176</volume><year>2018</year><fpage>404</fpage><lpage>408</lpage><pub-id pub-id-type="pmid">29205794</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal" id="sref71"><person-group person-group-type="author"><name><surname>Kummer</surname><given-names>E.</given-names></name><name><surname>Ban</surname><given-names>N.</given-names></name></person-group><article-title>Mechanisms and regulation of protein synthesis in mitochondria</article-title><source>Nat. Rev. Mol. Cell Biol.</source><volume>22</volume><year>2021</year><fpage>307</fpage><lpage>325</lpage><pub-id pub-id-type="pmid">33594280</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal" id="sref72"><person-group person-group-type="author"><name><surname>Kuzawa</surname><given-names>C.W.</given-names></name><name><surname>Chugani</surname><given-names>H.T.</given-names></name><name><surname>Grossman</surname><given-names>L.I.</given-names></name><name><surname>Lipovich</surname><given-names>L.</given-names></name><name><surname>Muzik</surname><given-names>O.</given-names></name><name><surname>Hof</surname><given-names>P.R.</given-names></name><name><surname>Wildman</surname><given-names>D.E.</given-names></name><name><surname>Sherwood</surname><given-names>C.C.</given-names></name><name><surname>Leonard</surname><given-names>W.R.</given-names></name><name><surname>Lange</surname><given-names>N.</given-names></name></person-group><article-title>Metabolic costs and evolutionary implications of human brain development</article-title><source>Proc. Natl. Acad. Sci. USA</source><volume>111</volume><year>2014</year><fpage>13010</fpage><lpage>13015</lpage><pub-id pub-id-type="pmid">25157149</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal" id="sref73"><person-group person-group-type="author"><name><surname>Kuzniewska</surname><given-names>B.</given-names></name><name><surname>Cysewski</surname><given-names>D.</given-names></name><name><surname>Wasilewski</surname><given-names>M.</given-names></name><name><surname>Sakowska</surname><given-names>P.</given-names></name><name><surname>Milek</surname><given-names>J.</given-names></name><name><surname>Kulinski</surname><given-names>T.M.</given-names></name><name><surname>Winiarski</surname><given-names>M.</given-names></name><name><surname>Kozielewicz</surname><given-names>P.</given-names></name><name><surname>Knapska</surname><given-names>E.</given-names></name><name><surname>Dadlez</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Mitochondrial protein biogenesis in the synapse is supported by local translation</article-title><source>EMBO Rep.</source><volume>21</volume><year>2020</year><object-id pub-id-type="publisher-id">e48882</object-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal" id="sref74"><person-group person-group-type="author"><name><surname>Lake</surname><given-names>N.J.</given-names></name><name><surname>Webb</surname><given-names>B.D.</given-names></name><name><surname>Stroud</surname><given-names>D.A.</given-names></name><name><surname>Richman</surname><given-names>T.R.</given-names></name><name><surname>Ruzzenente</surname><given-names>B.</given-names></name><name><surname>Compton</surname><given-names>A.G.</given-names></name><name><surname>Mountford</surname><given-names>H.S.</given-names></name><name><surname>Pulman</surname><given-names>J.</given-names></name><name><surname>Zangarelli</surname><given-names>C.</given-names></name><name><surname>Rio</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Biallelic mutations in MRPS34 lead to instability of the small mitoribosomal subunit and Leigh syndrome</article-title><source>Am. J. Hum. Genet.</source><volume>101</volume><year>2017</year><fpage>239</fpage><lpage>254</lpage><pub-id pub-id-type="pmid">28777931</pub-id></element-citation></ref><ref id="bib75"><element-citation publication-type="journal" id="sref75"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>C.E.</given-names></name><name><surname>Singleton</surname><given-names>K.S.</given-names></name><name><surname>Wallin</surname><given-names>M.</given-names></name><name><surname>Faundez</surname><given-names>V.</given-names></name></person-group><article-title>Rare genetic diseases: nature's experiments on human development</article-title><source>iScience</source><volume>23</volume><year>2020</year><object-id pub-id-type="publisher-id">101123</object-id></element-citation></ref><ref id="bib76"><element-citation publication-type="journal" id="sref76"><person-group person-group-type="author"><name><surname>Lesnik</surname><given-names>C.</given-names></name><name><surname>Golani-Armon</surname><given-names>A.</given-names></name><name><surname>Arava</surname><given-names>Y.</given-names></name></person-group><article-title>Localized translation near the mitochondrial outer membrane: an update</article-title><source>RNA Biol.</source><volume>12</volume><year>2015</year><fpage>801</fpage><lpage>809</lpage><pub-id pub-id-type="pmid">26151724</pub-id></element-citation></ref><ref id="bib77"><element-citation publication-type="journal" id="sref77"><person-group person-group-type="author"><name><surname>Li</surname><given-names>J.</given-names></name><name><surname>Ryan</surname><given-names>S.K.</given-names></name><name><surname>Deboer</surname><given-names>E.</given-names></name><name><surname>Cook</surname><given-names>K.</given-names></name><name><surname>Fitzgerald</surname><given-names>S.</given-names></name><name><surname>Lachman</surname><given-names>H.M.</given-names></name><name><surname>Wallace</surname><given-names>D.C.</given-names></name><name><surname>Goldberg</surname><given-names>E.M.</given-names></name><name><surname>Anderson</surname><given-names>S.A.</given-names></name></person-group><article-title>Mitochondrial deficits in human iPSC-derived neurons from patients with 22q11.2 deletion syndrome and schizophrenia</article-title><source>Transl. Psychiatry</source><volume>9</volume><year>2019</year><fpage>302</fpage><pub-id pub-id-type="pmid">31740674</pub-id></element-citation></ref><ref id="bib78"><element-citation publication-type="journal" id="sref78"><person-group person-group-type="author"><name><surname>Li</surname><given-names>S.</given-names></name><name><surname>Sheng</surname><given-names>Z.-H.</given-names></name></person-group><article-title>Energy matters: presynaptic metabolism and the maintenance of synaptic transmission</article-title><source>Nat. Rev. Neurosci.</source><volume>23</volume><year>2022</year><fpage>4</fpage><lpage>22</lpage><pub-id pub-id-type="pmid">34782781</pub-id></element-citation></ref><ref id="bib142"><element-citation publication-type="journal" id="optESyxmcHjxR"><person-group person-group-type="author"><name><surname>Li</surname><given-names>J.</given-names></name><name><surname>Tran</surname><given-names>O.T.</given-names></name><name><surname>Crowley</surname><given-names>T.B.</given-names></name><name><surname>Moore</surname><given-names>T.M.</given-names></name><name><surname>Zackai</surname><given-names>E.H.</given-names></name><name><surname>Emanuel</surname><given-names>B.S.</given-names></name><name><surname>McDonald-McGinn</surname><given-names>D.M.</given-names></name><name><surname>Gur</surname><given-names>R.E.</given-names></name><name><surname>Wallace</surname><given-names>D.C.</given-names></name><name><surname>Anderson</surname><given-names>S.A.</given-names></name></person-group><article-title>Association of mitochondrial biogenesis with variable penetrance of Schizophrenia</article-title><source>JAMA Psychiatry</source><volume>78</volume><year>2021</year><fpage>911</fpage><lpage>921</lpage><pub-id pub-id-type="pmid">34009292</pub-id></element-citation></ref><ref id="bib79"><element-citation publication-type="journal" id="sref79"><person-group person-group-type="author"><name><surname>Li</surname><given-names>S.</given-names></name><name><surname>Xiong</surname><given-names>G.-J.</given-names></name><name><surname>Huang</surname><given-names>N.</given-names></name><name><surname>Sheng</surname><given-names>Z.-H.</given-names></name></person-group><article-title>The cross-talk of energy sensing and mitochondrial anchoring sustains synaptic efficacy by maintaining presynaptic metabolism</article-title><source>Nat. Metab.</source><volume>2</volume><year>2020</year><fpage>1077</fpage><lpage>1095</lpage><pub-id pub-id-type="pmid">33020662</pub-id></element-citation></ref><ref id="bib80"><element-citation publication-type="journal" id="sref80"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Z.</given-names></name><name><surname>Schonberg</surname><given-names>R.</given-names></name><name><surname>Guidugli</surname><given-names>L.</given-names></name><name><surname>Johnson</surname><given-names>A.K.</given-names></name><name><surname>Arnovitz</surname><given-names>S.</given-names></name><name><surname>Yang</surname><given-names>S.</given-names></name><name><surname>Scafidi</surname><given-names>J.</given-names></name><name><surname>Summar</surname><given-names>M.L.</given-names></name><name><surname>Vezina</surname><given-names>G.</given-names></name><name><surname>Das</surname><given-names>S.</given-names></name><etal/></person-group><article-title>A novel mutation in the promoter of RARS2 causes pontocerebellar hypoplasia in two siblings</article-title><source>J.&#x000a0;Hum. Genet.</source><volume>60</volume><year>2015</year><fpage>363</fpage><lpage>369</lpage><pub-id pub-id-type="pmid">25809939</pub-id></element-citation></ref><ref id="bib81"><element-citation publication-type="journal" id="sref81"><person-group person-group-type="author"><name><surname>Licznerski</surname><given-names>P.</given-names></name><name><surname>Park</surname><given-names>H.-A.</given-names></name><name><surname>Rolyan</surname><given-names>H.</given-names></name><name><surname>Chen</surname><given-names>R.</given-names></name><name><surname>Mnatsakanyan</surname><given-names>N.</given-names></name><name><surname>Miranda</surname><given-names>P.</given-names></name><name><surname>Graham</surname><given-names>M.</given-names></name><name><surname>Wu</surname><given-names>J.</given-names></name><name><surname>Cruz-Reyes</surname><given-names>N.</given-names></name><name><surname>Mehta</surname><given-names>N.</given-names></name><etal/></person-group><article-title>ATP synthase c-subunit leak causes aberrant cellular metabolism in fragile X syndrome</article-title><source>Cell</source><volume>182</volume><year>2020</year><fpage>1170</fpage><lpage>1185.e9</lpage><pub-id pub-id-type="pmid">32795412</pub-id></element-citation></ref><ref id="bib82"><element-citation publication-type="journal" id="sref82"><person-group person-group-type="author"><name><surname>Liesa</surname><given-names>M.</given-names></name><name><surname>Shirihai</surname><given-names>O.S.</given-names></name></person-group><article-title>Mitochondrial dynamics in the regulation of nutrient utilization and energy expenditure</article-title><source>Cell Metab.</source><volume>17</volume><year>2013</year><fpage>491</fpage><lpage>506</lpage><pub-id pub-id-type="pmid">23562075</pub-id></element-citation></ref><ref id="bib83"><element-citation publication-type="journal" id="sref83"><person-group person-group-type="author"><name><surname>Lucas</surname><given-names>S.J.</given-names></name><name><surname>Michel</surname><given-names>C.B.</given-names></name><name><surname>Marra</surname><given-names>V.</given-names></name><name><surname>Smalley</surname><given-names>J.L.</given-names></name><name><surname>Hennig</surname><given-names>M.H.</given-names></name><name><surname>Graham</surname><given-names>B.P.</given-names></name><name><surname>Forsythe</surname><given-names>I.D.</given-names></name></person-group><article-title>Glucose and lactate as metabolic constraints on presynaptic transmission at an excitatory synapse</article-title><source>J.&#x000a0;Physiol.</source><volume>596</volume><year>2018</year><fpage>1699</fpage><lpage>1721</lpage><pub-id pub-id-type="pmid">29430661</pub-id></element-citation></ref><ref id="bib84"><element-citation publication-type="journal" id="sref84"><person-group person-group-type="author"><name><surname>Lujan</surname><given-names>B.</given-names></name><name><surname>Kushmerick</surname><given-names>C.</given-names></name><name><surname>Banerjee</surname><given-names>T.D.</given-names></name><name><surname>Dagda</surname><given-names>R.K.</given-names></name><name><surname>Renden</surname><given-names>R.</given-names></name></person-group><article-title>Glycolysis selectively shapes the presynaptic action potential waveform</article-title><source>J.&#x000a0;Neurophysiol.</source><volume>116</volume><year>2016</year><fpage>2523</fpage><lpage>2540</lpage><pub-id pub-id-type="pmid">27605535</pub-id></element-citation></ref><ref id="bib85"><element-citation publication-type="journal" id="sref85"><person-group person-group-type="author"><name><surname>Lujan</surname><given-names>B.J.</given-names></name><name><surname>Singh</surname><given-names>M.</given-names></name><name><surname>Singh</surname><given-names>A.</given-names></name><name><surname>Renden</surname><given-names>R.B.</given-names></name></person-group><article-title>Developmental shift to mitochondrial respiration for energetic support of sustained transmission during maturation at the calyx of Held</article-title><source>J.&#x000a0;Neurophysiol.</source><volume>126</volume><year>2021</year><fpage>976</fpage><lpage>996</lpage><pub-id pub-id-type="pmid">34432991</pub-id></element-citation></ref><ref id="bib86"><element-citation publication-type="journal" id="sref86"><person-group person-group-type="author"><name><surname>McDonald-McGinn</surname><given-names>D.M.</given-names></name><name><surname>Sullivan</surname><given-names>K.E.</given-names></name><name><surname>Marino</surname><given-names>B.</given-names></name><name><surname>Philip</surname><given-names>N.</given-names></name><name><surname>Swillen</surname><given-names>A.</given-names></name><name><surname>Vorstman</surname><given-names>J.A.S.</given-names></name><name><surname>Zackai</surname><given-names>E.H.</given-names></name><name><surname>Emanuel</surname><given-names>B.S.</given-names></name><name><surname>Vermeesch</surname><given-names>J.R.</given-names></name><name><surname>Morrow</surname><given-names>B.E.</given-names></name><etal/></person-group><article-title>22q11.2 deletion syndrome</article-title><source>Nat. Rev. Dis. Primers</source><volume>1</volume><year>2015</year><fpage>15071</fpage><pub-id pub-id-type="pmid">27189754</pub-id></element-citation></ref><ref id="bib87"><element-citation publication-type="journal" id="sref87"><person-group person-group-type="author"><name><surname>Miller</surname><given-names>C.</given-names></name><name><surname>Saada</surname><given-names>A.</given-names></name><name><surname>Shaul</surname><given-names>N.</given-names></name><name><surname>Shabtai</surname><given-names>N.</given-names></name><name><surname>Ben-Shalom</surname><given-names>E.</given-names></name><name><surname>Shaag</surname><given-names>A.</given-names></name><name><surname>Hershkovitz</surname><given-names>E.</given-names></name><name><surname>Elpeleg</surname><given-names>O.</given-names></name></person-group><article-title>Defective mitochondrial translation caused by a ribosomal protein (MRPS16) mutation</article-title><source>Ann. Neurol.</source><volume>56</volume><year>2004</year><fpage>734</fpage><lpage>738</lpage><pub-id pub-id-type="pmid">15505824</pub-id></element-citation></ref><ref id="bib88"><element-citation publication-type="journal" id="sref88"><person-group person-group-type="author"><name><surname>Mishra</surname><given-names>P.</given-names></name><name><surname>Chan</surname><given-names>D.C.</given-names></name></person-group><article-title>Metabolic regulation of mitochondrial dynamics</article-title><source>J.&#x000a0;Cell Biol.</source><volume>212</volume><year>2016</year><fpage>379</fpage><lpage>387</lpage><pub-id pub-id-type="pmid">26858267</pub-id></element-citation></ref><ref id="bib89"><element-citation publication-type="journal" id="sref89"><person-group person-group-type="author"><name><surname>Motahari</surname><given-names>Z.</given-names></name><name><surname>Moody</surname><given-names>S.A.</given-names></name><name><surname>Maynard</surname><given-names>T.M.</given-names></name><name><surname>LaMantia</surname><given-names>A.S.</given-names></name></person-group><article-title>In the line-up: deleted genes associated with DiGeorge/22q11.2 deletion syndrome: are they all suspects?</article-title><source>J.&#x000a0;Neurodev. Disord.</source><volume>11</volume><year>2019</year><fpage>7</fpage><pub-id pub-id-type="pmid">31174463</pub-id></element-citation></ref><ref id="bib90"><element-citation publication-type="journal" id="sref90"><person-group person-group-type="author"><name><surname>Musante</surname><given-names>L.</given-names></name><name><surname>P&#x000fc;ttmann</surname><given-names>L.</given-names></name><name><surname>Kahrizi</surname><given-names>K.</given-names></name><name><surname>Garshasbi</surname><given-names>M.</given-names></name><name><surname>Hu</surname><given-names>H.</given-names></name><name><surname>Stehr</surname><given-names>H.</given-names></name><name><surname>Lipkowitz</surname><given-names>B.</given-names></name><name><surname>Otto</surname><given-names>S.</given-names></name><name><surname>Jensen</surname><given-names>L.R.</given-names></name><name><surname>Tzschach</surname><given-names>A.</given-names></name><etal/></person-group><article-title>Mutations of the aminoacyl-tRNA-synthetases SARS and WARS2 are implicated in the etiology of autosomal recessive intellectual disability</article-title><source>Hum. Mutat.</source><volume>38</volume><year>2017</year><fpage>621</fpage><lpage>636</lpage><pub-id pub-id-type="pmid">28236339</pub-id></element-citation></ref><ref id="bib91"><element-citation publication-type="journal" id="sref91"><person-group person-group-type="author"><name><surname>Ng</surname><given-names>Y.S.</given-names></name><name><surname>Martikainen</surname><given-names>M.H.</given-names></name><name><surname>Gorman</surname><given-names>G.S.</given-names></name><name><surname>Blain</surname><given-names>A.</given-names></name><name><surname>Bugiardini</surname><given-names>E.</given-names></name><name><surname>Bunting</surname><given-names>A.</given-names></name><name><surname>Schaefer</surname><given-names>A.M.</given-names></name><name><surname>Alston</surname><given-names>C.L.</given-names></name><name><surname>Blakely</surname><given-names>E.L.</given-names></name><name><surname>Sharma</surname><given-names>S.</given-names></name><etal/></person-group><article-title>Pathogenic variants in MT-ATP6: a United Kingdom-based mitochondrial disease cohort study</article-title><source>Ann. Neurol.</source><volume>86</volume><year>2019</year><fpage>310</fpage><lpage>315</lpage><pub-id pub-id-type="pmid">31187502</pub-id></element-citation></ref><ref id="bib92"><element-citation publication-type="journal" id="sref92"><person-group person-group-type="author"><name><surname>Niyazov</surname><given-names>D.M.</given-names></name><name><surname>Kahler</surname><given-names>S.G.</given-names></name><name><surname>Frye</surname><given-names>R.E.</given-names></name></person-group><article-title>Primary mitochondrial disease and secondary mitochondrial dysfunction: importance of distinction for diagnosis and treatment</article-title><source>Mol. Syndromol.</source><volume>7</volume><year>2016</year><fpage>122</fpage><lpage>137</lpage><pub-id pub-id-type="pmid">27587988</pub-id></element-citation></ref><ref id="bib93"><element-citation publication-type="journal" id="sref93"><person-group person-group-type="author"><name><surname>Oyarz&#x000e1;bal</surname><given-names>A.</given-names></name><name><surname>Musokhranova</surname><given-names>U.</given-names></name><name><surname>Lf</surname><given-names>B.</given-names></name><name><surname>Garc&#x000ed;a-Cazorla</surname><given-names>A.</given-names></name></person-group><article-title>Energy metabolism in childhood neurodevelopmental disorders</article-title><source>EBioMedicine</source><volume>69</volume><year>2021</year><fpage>103474</fpage><pub-id pub-id-type="pmid">34256347</pub-id></element-citation></ref><ref id="bib94"><element-citation publication-type="journal" id="sref94"><person-group person-group-type="author"><name><surname>Palmer</surname><given-names>C.S.</given-names></name><name><surname>Anderson</surname><given-names>A.J.</given-names></name><name><surname>Stojanovski</surname><given-names>D.</given-names></name></person-group><article-title>Mitochondrial protein import dysfunction:&#x000a0;mitochondrial disease, neurodegenerative disease and cancer</article-title><source>FEBS Lett.</source><volume>595</volume><year>2021</year><fpage>1107</fpage><lpage>1131</lpage><pub-id pub-id-type="pmid">33314127</pub-id></element-citation></ref><ref id="bib95"><element-citation publication-type="journal" id="sref95"><person-group person-group-type="author"><name><surname>Parra</surname><given-names>S.P.</given-names></name><name><surname>Heckers</surname><given-names>S.H.</given-names></name><name><surname>Wilcox</surname><given-names>W.R.</given-names></name><name><surname>Mcknight</surname><given-names>C.D.</given-names></name><name><surname>Jinnah</surname><given-names>H.A.</given-names></name></person-group><article-title>The emerging neurological spectrum of AARS2-associated disorders</article-title><source>Parkinsonism Relat. Disord.</source><volume>93</volume><year>2021</year><fpage>50</fpage><lpage>54</lpage><pub-id pub-id-type="pmid">34784527</pub-id></element-citation></ref><ref id="bib96"><element-citation publication-type="journal" id="sref96"><person-group person-group-type="author"><name><surname>Patgiri</surname><given-names>A.</given-names></name><name><surname>Skinner</surname><given-names>O.S.</given-names></name><name><surname>Miyazaki</surname><given-names>Y.</given-names></name><name><surname>Schleifer</surname><given-names>G.</given-names></name><name><surname>Marutani</surname><given-names>E.</given-names></name><name><surname>Shah</surname><given-names>H.</given-names></name><name><surname>Sharma</surname><given-names>R.</given-names></name><name><surname>Goodman</surname><given-names>R.P.</given-names></name><name><surname>To</surname><given-names>T.-L.</given-names></name><name><surname>Robert Bao</surname><given-names>X.</given-names></name><etal/></person-group><article-title>An engineered enzyme that targets circulating lactate to alleviate intracellular NADH: NAD+ imbalance</article-title><source>Nat. Biotechnol.</source><volume>38</volume><year>2020</year><fpage>309</fpage><lpage>313</lpage><pub-id pub-id-type="pmid">31932725</pub-id></element-citation></ref><ref id="bib97"><element-citation publication-type="journal" id="sref97"><person-group person-group-type="author"><name><surname>Pei</surname><given-names>L.</given-names></name><name><surname>Wallace</surname><given-names>D.C.</given-names></name></person-group><article-title>Mitochondrial etiology of neuropsychiatric disorders</article-title><source>Biol. Psychiatry</source><volume>83</volume><year>2018</year><fpage>722</fpage><lpage>730</lpage><pub-id pub-id-type="pmid">29290371</pub-id></element-citation></ref><ref id="bib98"><element-citation publication-type="journal" id="sref98"><person-group person-group-type="author"><name><surname>Pons</surname><given-names>R.</given-names></name><name><surname>Andreu</surname><given-names>A.L.</given-names></name><name><surname>Checcarelli</surname><given-names>N.</given-names></name><name><surname>Vil&#x000e0;</surname><given-names>M.R.</given-names></name><name><surname>Engelstad</surname><given-names>K.</given-names></name><name><surname>Sue</surname><given-names>C.M.</given-names></name><name><surname>Shungu</surname><given-names>D.</given-names></name><name><surname>Haggerty</surname><given-names>R.</given-names></name><name><surname>de Vivo</surname><given-names>D.C.</given-names></name><name><surname>DiMauro</surname><given-names>S.</given-names></name></person-group><article-title>Mitochondrial DNA abnormalities and autistic spectrum disorders</article-title><source>J.&#x000a0;Pediatr.</source><volume>144</volume><year>2004</year><fpage>81</fpage><lpage>85</lpage><pub-id pub-id-type="pmid">14722523</pub-id></element-citation></ref><ref id="bib99"><element-citation publication-type="journal" id="sref99"><person-group person-group-type="author"><name><surname>Rangaraju</surname><given-names>V.</given-names></name><name><surname>Lauterbach</surname><given-names>M.</given-names></name><name><surname>Schuman</surname><given-names>E.M.</given-names></name></person-group><article-title>Spatially stable mitochondrial compartments fuel local translation during plasticity</article-title><source>Cell</source><volume>176</volume><year>2019</year><fpage>73</fpage><lpage>84.e15</lpage><pub-id pub-id-type="pmid">30612742</pub-id></element-citation></ref><ref id="bib100"><element-citation publication-type="journal" id="sref100"><person-group person-group-type="author"><name><surname>Rankin</surname><given-names>J.</given-names></name><name><surname>Brown</surname><given-names>R.</given-names></name><name><surname>Dobyns</surname><given-names>W.B.</given-names></name><name><surname>Harington</surname><given-names>J.</given-names></name><name><surname>Patel</surname><given-names>J.</given-names></name><name><surname>Quinn</surname><given-names>M.</given-names></name><name><surname>Brown</surname><given-names>G.</given-names></name></person-group><article-title>Pontocerebellar hypoplasia type 6: a British case with PEHO-like features</article-title><source>Am. J. Med. Genet.</source><volume>152A</volume><year>2010</year><fpage>2079</fpage><lpage>2084</lpage><pub-id pub-id-type="pmid">20635367</pub-id></element-citation></ref><ref id="bib101"><element-citation publication-type="journal" id="sref101"><person-group person-group-type="author"><name><surname>Rath</surname><given-names>S.</given-names></name><name><surname>Sharma</surname><given-names>R.</given-names></name><name><surname>Gupta</surname><given-names>R.</given-names></name><name><surname>Ast</surname><given-names>T.</given-names></name><name><surname>Chan</surname><given-names>C.</given-names></name><name><surname>Durham</surname><given-names>T.J.</given-names></name><name><surname>Goodman</surname><given-names>R.P.</given-names></name><name><surname>Grabarek</surname><given-names>Z.</given-names></name><name><surname>Haas</surname><given-names>M.E.</given-names></name><name><surname>Hung</surname><given-names>W.H.W.</given-names></name><etal/></person-group><article-title>MitoCarta3.0: an updated mitochondrial proteome now with sub-organelle localization and pathway annotations</article-title><source>Nucleic Acids Res.</source><volume>49</volume><year>2021</year><fpage>D1541</fpage><lpage>D1547</lpage><pub-id pub-id-type="pmid">33174596</pub-id></element-citation></ref><ref id="bib102"><element-citation publication-type="journal" id="sref102"><person-group person-group-type="author"><name><surname>Rich</surname><given-names>P.</given-names></name></person-group><article-title>Chemiosmotic coupling: the cost of living</article-title><source>Nature</source><volume>421</volume><year>2003</year><fpage>583</fpage><pub-id pub-id-type="pmid">12571574</pub-id></element-citation></ref><ref id="bib103"><element-citation publication-type="journal" id="sref103"><person-group person-group-type="author"><name><surname>Richter</surname><given-names>J.D.</given-names></name><name><surname>Bassell</surname><given-names>G.J.</given-names></name><name><surname>Klann</surname><given-names>E.</given-names></name></person-group><article-title>Dysregulation and restoration of translational homeostasis in fragile X syndrome</article-title><source>Nat. Rev. Neurosci.</source><volume>16</volume><year>2015</year><fpage>595</fpage><lpage>605</lpage><pub-id pub-id-type="pmid">26350240</pub-id></element-citation></ref><ref id="bib104"><element-citation publication-type="journal" id="sref104"><person-group person-group-type="author"><name><surname>Rossignol</surname><given-names>R.</given-names></name><name><surname>Faustin</surname><given-names>B.</given-names></name><name><surname>Rocher</surname><given-names>C.</given-names></name><name><surname>Malgat</surname><given-names>M.</given-names></name><name><surname>Mazat</surname><given-names>J.P.</given-names></name><name><surname>Letellier</surname><given-names>T.</given-names></name></person-group><article-title>Mitochondrial threshold effects</article-title><source>Biochem. J.</source><volume>370</volume><year>2003</year><fpage>751</fpage><lpage>762</lpage><pub-id pub-id-type="pmid">12467494</pub-id></element-citation></ref><ref id="bib105"><element-citation publication-type="journal" id="sref105"><person-group person-group-type="author"><name><surname>Ryzhkova</surname><given-names>A.I.</given-names></name><name><surname>Sazonova</surname><given-names>M.A.</given-names></name><name><surname>Sinyov</surname><given-names>V.V.</given-names></name><name><surname>Galitsyna</surname><given-names>E.V.</given-names></name><name><surname>Chicheva</surname><given-names>M.M.</given-names></name><name><surname>Melnichenko</surname><given-names>A.A.</given-names></name><name><surname>Grechko</surname><given-names>A.V.</given-names></name><name><surname>Postnov</surname><given-names>A.Y.</given-names></name><name><surname>Orekhov</surname><given-names>A.N.</given-names></name><name><surname>Shkurat</surname><given-names>T.P.</given-names></name></person-group><article-title>Mitochondrial diseases caused by mtDNA mutations: a mini-review</article-title><source>Ther. Clin. Risk Manag.</source><volume>14</volume><year>2018</year><fpage>1933</fpage><lpage>1942</lpage><pub-id pub-id-type="pmid">30349272</pub-id></element-citation></ref><ref id="bib106"><element-citation publication-type="journal" id="sref106"><person-group person-group-type="author"><name><surname>Saada</surname><given-names>A.</given-names></name><name><surname>Shaag</surname><given-names>A.</given-names></name><name><surname>Arnon</surname><given-names>S.</given-names></name><name><surname>Dolfin</surname><given-names>T.</given-names></name><name><surname>Miller</surname><given-names>C.</given-names></name><name><surname>Fuchs-Telem</surname><given-names>D.</given-names></name><name><surname>Lombes</surname><given-names>A.</given-names></name><name><surname>Elpeleg</surname><given-names>O.</given-names></name></person-group><article-title>Antenatal mitochondrial disease caused by mitochondrial ribosomal protein (MRPS22) mutation</article-title><source>J.&#x000a0;Med. Genet.</source><volume>44</volume><year>2007</year><fpage>784</fpage><lpage>786</lpage><pub-id pub-id-type="pmid">17873122</pub-id></element-citation></ref><ref id="bib107"><element-citation publication-type="book" id="sref107"><person-group person-group-type="author"><name><surname>Saini</surname><given-names>A.K.</given-names></name><name><surname>Kumar</surname><given-names>V.</given-names></name></person-group><part-title>Chapter 2-Ribosome structure</part-title><person-group person-group-type="editor"><name><surname>Kumar</surname><given-names>V.</given-names></name></person-group><source>Emerging Concepts in Ribosome Structure, Biogenesis, and Function</source><year>2021</year><publisher-name>Academic Press</publisher-name><fpage>15</fpage><lpage>31</lpage></element-citation></ref><ref id="bib108"><element-citation publication-type="journal" id="sref108"><person-group person-group-type="author"><name><surname>Savatt</surname><given-names>J.M.</given-names></name><name><surname>Myers</surname><given-names>S.M.</given-names></name></person-group><article-title>Genetic testing in neurodevelopmental disorders</article-title><source>Front. Pediatr.</source><volume>9</volume><year>2021</year><fpage>526779</fpage><pub-id pub-id-type="pmid">33681094</pub-id></element-citation></ref><ref id="bib109"><element-citation publication-type="journal" id="sref109"><person-group person-group-type="author"><name><surname>Schubert Baldo</surname><given-names>M.</given-names></name><name><surname>Vilarinho</surname><given-names>L.</given-names></name></person-group><article-title>Molecular basis of Leigh syndrome: a current look</article-title><source>Orphanet J. Rare Dis.</source><volume>15</volume><year>2020</year><fpage>31</fpage><pub-id pub-id-type="pmid">31996241</pub-id></element-citation></ref><ref id="bib110"><element-citation publication-type="journal" id="sref110"><person-group person-group-type="author"><name><surname>Serre</surname><given-names>V.</given-names></name><name><surname>Rozanska</surname><given-names>A.</given-names></name><name><surname>Beinat</surname><given-names>M.</given-names></name><name><surname>Chretien</surname><given-names>D.</given-names></name><name><surname>Boddaert</surname><given-names>N.</given-names></name><name><surname>Munnich</surname><given-names>A.</given-names></name><name><surname>R&#x000f6;tig</surname><given-names>A.</given-names></name><name><surname>Chrzanowska-Lightowlers</surname><given-names>Z.M.</given-names></name></person-group><article-title>Mutations in mitochondrial ribosomal protein MRPL12 leads to growth retardation, neurological deterioration and mitochondrial translation deficiency</article-title><source>Biochim. Biophys. Acta</source><volume>1832</volume><year>2013</year><fpage>1304</fpage><lpage>1312</lpage><pub-id pub-id-type="pmid">23603806</pub-id></element-citation></ref><ref id="bib111"><element-citation publication-type="journal" id="sref111"><person-group person-group-type="author"><name><surname>Sharma</surname><given-names>R.</given-names></name><name><surname>Reinstadler</surname><given-names>B.</given-names></name><name><surname>Engelstad</surname><given-names>K.</given-names></name><name><surname>Skinner</surname><given-names>O.S.</given-names></name><name><surname>Stackowitz</surname><given-names>E.</given-names></name><name><surname>Haller</surname><given-names>R.G.</given-names></name><name><surname>Clish</surname><given-names>C.B.</given-names></name><name><surname>Pierce</surname><given-names>K.</given-names></name><name><surname>Walker</surname><given-names>M.A.</given-names></name><name><surname>Fryer</surname><given-names>R.</given-names></name><etal/></person-group><article-title>Circulating markers of NADH-reductive stress correlate with mitochondrial disease severity</article-title><source>J.&#x000a0;Clin. Invest.</source><volume>131</volume><year>2021</year><pub-id pub-id-type="doi">10.1172/JCI136055</pub-id></element-citation></ref><ref id="bib112"><element-citation publication-type="journal" id="sref112"><person-group person-group-type="author"><name><surname>Shcherbakov</surname><given-names>D.</given-names></name><name><surname>Juskeviciene</surname><given-names>R.</given-names></name><name><surname>Cort&#x000e9;s Sanch&#x000f3;n</surname><given-names>A.</given-names></name><name><surname>Brilkova</surname><given-names>M.</given-names></name><name><surname>Rehrauer</surname><given-names>H.</given-names></name><name><surname>Laczko</surname><given-names>E.</given-names></name><name><surname>B&#x000f6;ttger</surname><given-names>E.C.</given-names></name></person-group><article-title>Mitochondrial mistranslation in brain provokes a metabolic response which mitigates the age-associated decline in mitochondrial gene expression</article-title><source>Int. J. Mol. Sci.</source><volume>22</volume><year>2021</year><fpage>2746</fpage><pub-id pub-id-type="pmid">33803109</pub-id></element-citation></ref><ref id="bib113"><element-citation publication-type="journal" id="sref113"><person-group person-group-type="author"><name><surname>Shulyakova</surname><given-names>N.</given-names></name><name><surname>Andreazza</surname><given-names>A.C.</given-names></name><name><surname>Mills</surname><given-names>L.R.</given-names></name><name><surname>Eubanks</surname><given-names>J.H.</given-names></name></person-group><article-title>Mitochondrial dysfunction in the pathogenesis of Rett syndrome: implications for mitochondria-targeted therapies</article-title><source>Front. Cell. Neurosci.</source><volume>11</volume><year>2017</year><fpage>58</fpage><pub-id pub-id-type="pmid">28352216</pub-id></element-citation></ref><ref id="bib114"><element-citation publication-type="journal" id="sref114"><person-group person-group-type="author"><name><surname>Sissler</surname><given-names>M.</given-names></name><name><surname>Gonz&#x000e1;lez-Serrano</surname><given-names>L.E.</given-names></name><name><surname>Westhof</surname><given-names>E.</given-names></name></person-group><article-title>Recent advances in mitochondrial aminoacyl-tRNA synthetases and disease</article-title><source>Trends Mol. Med.</source><volume>23</volume><year>2017</year><fpage>693</fpage><lpage>708</lpage><pub-id pub-id-type="pmid">28716624</pub-id></element-citation></ref><ref id="bib115"><element-citation publication-type="journal" id="sref115"><person-group person-group-type="author"><name><surname>Skorvanek</surname><given-names>M.</given-names></name><name><surname>Rektorova</surname><given-names>I.</given-names></name><name><surname>Mandemakers</surname><given-names>W.</given-names></name><name><surname>Wagner</surname><given-names>M.</given-names></name><name><surname>Steinfeld</surname><given-names>R.</given-names></name><name><surname>Orec</surname><given-names>L.</given-names></name><name><surname>Han</surname><given-names>V.</given-names></name><name><surname>Pavelekova</surname><given-names>P.</given-names></name><name><surname>Lackova</surname><given-names>A.</given-names></name><name><surname>Kulcsarova</surname><given-names>K.</given-names></name><etal/></person-group><article-title>WARS2 mutations cause dopa-responsive early-onset parkinsonism and progressive myoclonus ataxia</article-title><source>Parkinsonism Relat. Disord.</source><volume>94</volume><year>2022</year><fpage>54</fpage><lpage>61</lpage><pub-id pub-id-type="pmid">34890876</pub-id></element-citation></ref><ref id="bib116"><element-citation publication-type="journal" id="sref116"><person-group person-group-type="author"><name><surname>Smits</surname><given-names>P.</given-names></name><name><surname>Saada</surname><given-names>A.</given-names></name><name><surname>Wortmann</surname><given-names>S.B.</given-names></name><name><surname>Heister</surname><given-names>A.J.</given-names></name><name><surname>Brink</surname><given-names>M.</given-names></name><name><surname>Pfundt</surname><given-names>R.</given-names></name><name><surname>Miller</surname><given-names>C.</given-names></name><name><surname>Haas</surname><given-names>D.</given-names></name><name><surname>Hantschmann</surname><given-names>R.</given-names></name><name><surname>Rodenburg</surname><given-names>R.J.T.</given-names></name><etal/></person-group><article-title>Mutation in mitochondrial ribosomal protein MRPS22 leads to Cornelia de Lange-like phenotype, brain abnormalities and hypertrophic cardiomyopathy</article-title><source>Eur. J. Hum. Genet.</source><volume>19</volume><year>2011</year><fpage>394</fpage><lpage>399</lpage><pub-id pub-id-type="pmid">21189481</pub-id></element-citation></ref><ref id="bib117"><element-citation publication-type="journal" id="sref117"><person-group person-group-type="author"><name><surname>Sobieski</surname><given-names>C.</given-names></name><name><surname>Fitzpatrick</surname><given-names>M.J.</given-names></name><name><surname>Mennerick</surname><given-names>S.J.</given-names></name></person-group><article-title>Differential presynaptic ATP supply for basal and high-demand transmission. The journal of neuroscience:</article-title><source>J.&#x000a0;Neurosci.</source><volume>37</volume><year>2017</year><fpage>1888</fpage><lpage>1899</lpage><pub-id pub-id-type="pmid">28093477</pub-id></element-citation></ref><ref id="bib118"><element-citation publication-type="journal" id="sref118"><person-group person-group-type="author"><name><surname>Sokoloff</surname><given-names>L.</given-names></name></person-group><article-title>Energetics of functional activation in neural tissues</article-title><source>Neurochem. Res.</source><volume>24</volume><year>1999</year><fpage>321</fpage><lpage>329</lpage><pub-id pub-id-type="pmid">9972882</pub-id></element-citation></ref><ref id="bib119"><element-citation publication-type="journal" id="sref119"><person-group person-group-type="author"><name><surname>Solmi</surname><given-names>M.</given-names></name><name><surname>Radua</surname><given-names>J.</given-names></name><name><surname>Olivola</surname><given-names>M.</given-names></name><name><surname>Croce</surname><given-names>E.</given-names></name><name><surname>Soardo</surname><given-names>L.</given-names></name><name><surname>Salazar de Pablo</surname><given-names>G.</given-names></name><name><surname>Il Shin</surname><given-names>J.</given-names></name><name><surname>Kirkbride</surname><given-names>J.B.</given-names></name><name><surname>Jones</surname><given-names>P.</given-names></name><name><surname>Kim</surname><given-names>J.H.</given-names></name><etal/></person-group><article-title>Age at onset of mental disorders worldwide: large-scale meta-analysis of 192 epidemiological studies</article-title><source>Mol. Psychiatry</source><volume>27</volume><year>2022</year><fpage>281</fpage><lpage>295</lpage><pub-id pub-id-type="pmid">34079068</pub-id></element-citation></ref><ref id="bib120"><element-citation publication-type="journal" id="sref120"><person-group person-group-type="author"><name><surname>Spalding</surname><given-names>K.L.</given-names></name><name><surname>Bergmann</surname><given-names>O.</given-names></name><name><surname>Alkass</surname><given-names>K.</given-names></name><name><surname>Bernard</surname><given-names>S.</given-names></name><name><surname>Salehpour</surname><given-names>M.</given-names></name><name><surname>Huttner</surname><given-names>H.B.</given-names></name><name><surname>Bostr&#x000f6;m</surname><given-names>E.</given-names></name><name><surname>Westerlund</surname><given-names>I.</given-names></name><name><surname>Vial</surname><given-names>C.</given-names></name><name><surname>Buchholz</surname><given-names>B.A.</given-names></name><etal/></person-group><article-title>Dynamics of hippocampal neurogenesis in adult humans</article-title><source>Cell</source><volume>153</volume><year>2013</year><fpage>1219</fpage><lpage>1227</lpage><pub-id pub-id-type="pmid">23746839</pub-id></element-citation></ref><ref id="bib121"><element-citation publication-type="journal" id="sref121"><person-group person-group-type="author"><name><surname>Spillane</surname><given-names>M.</given-names></name><name><surname>Ketschek</surname><given-names>A.</given-names></name><name><surname>Merianda</surname><given-names>T.T.</given-names></name><name><surname>Twiss</surname><given-names>J.L.</given-names></name><name><surname>Gallo</surname><given-names>G.</given-names></name></person-group><article-title>Mitochondria coordinate sites of axon branching through localized intra-axonal protein synthesis</article-title><source>Cell Rep.</source><volume>5</volume><year>2013</year><fpage>1564</fpage><lpage>1575</lpage><pub-id pub-id-type="pmid">24332852</pub-id></element-citation></ref><ref id="bib122"><element-citation publication-type="journal" id="sref122"><person-group person-group-type="author"><name><surname>Spinelli</surname><given-names>J.B.</given-names></name><name><surname>Haigis</surname><given-names>M.C.</given-names></name></person-group><article-title>The multifaceted contributions of mitochondria to cellular metabolism</article-title><source>Nat. Cell Biol.</source><volume>20</volume><year>2018</year><fpage>745</fpage><lpage>754</lpage><pub-id pub-id-type="pmid">29950572</pub-id></element-citation></ref><ref id="bib123"><element-citation publication-type="journal" id="sref123"><person-group person-group-type="author"><name><surname>Steenweg</surname><given-names>M.E.</given-names></name><name><surname>Ghezzi</surname><given-names>D.</given-names></name><name><surname>Haack</surname><given-names>T.</given-names></name><name><surname>Abbink</surname><given-names>T.E.M.</given-names></name><name><surname>Martinelli</surname><given-names>D.</given-names></name><name><surname>van Berkel</surname><given-names>C.G.M.</given-names></name><name><surname>Bley</surname><given-names>A.</given-names></name><name><surname>Diogo</surname><given-names>L.</given-names></name><name><surname>Grillo</surname><given-names>E.</given-names></name><name><surname>Te Water Naud&#x000e9;</surname><given-names>J.</given-names></name><etal/></person-group><article-title>Leukoencephalopathy with thalamus and brainstem involvement and high lactate &#x02018;LTBL&#x02019; caused by EARS2 mutations</article-title><source>Brain</source><volume>135</volume><year>2012</year><fpage>1387</fpage><lpage>1394</lpage><pub-id pub-id-type="pmid">22492562</pub-id></element-citation></ref><ref id="bib124"><element-citation publication-type="journal" id="sref124"><person-group person-group-type="author"><name><surname>Steiner</surname><given-names>P.</given-names></name></person-group><article-title>Brain fuel utilization in the developing brain</article-title><source>Ann. Nutr. Metab.</source><volume>75</volume><issue>Suppl 1</issue><year>2019</year><fpage>8</fpage><lpage>18</lpage><pub-id pub-id-type="pmid">32564020</pub-id></element-citation></ref><ref id="bib125"><element-citation publication-type="journal" id="sref125"><person-group person-group-type="author"><name><surname>Talim</surname><given-names>B.</given-names></name><name><surname>Pyle</surname><given-names>A.</given-names></name><name><surname>Griffin</surname><given-names>H.</given-names></name><name><surname>Topaloglu</surname><given-names>H.</given-names></name><name><surname>Tokatli</surname><given-names>A.</given-names></name><name><surname>Keogh</surname><given-names>M.J.</given-names></name><name><surname>Santibanez-Koref</surname><given-names>M.</given-names></name><name><surname>Chinnery</surname><given-names>P.F.</given-names></name><name><surname>Horvath</surname><given-names>R.</given-names></name></person-group><article-title>Multisystem fatal infantile disease caused by a novel homozygous EARS2 mutation</article-title><source>Brain</source><volume>136</volume><year>2013</year><fpage>e228</fpage><pub-id pub-id-type="pmid">23008233</pub-id></element-citation></ref><ref id="bib126"><element-citation publication-type="journal" id="sref126"><person-group person-group-type="author"><name><surname>Titov</surname><given-names>D.V.</given-names></name><name><surname>Cracan</surname><given-names>V.</given-names></name><name><surname>Goodman</surname><given-names>R.P.</given-names></name><name><surname>Peng</surname><given-names>J.</given-names></name><name><surname>Grabarek</surname><given-names>Z.</given-names></name><name><surname>Mootha</surname><given-names>V.K.</given-names></name></person-group><article-title>Complementation of mitochondrial electron transport chain by manipulation of the NAD+/NADH ratio</article-title><source>Science</source><volume>352</volume><year>2016</year><fpage>231</fpage><lpage>235</lpage><pub-id pub-id-type="pmid">27124460</pub-id></element-citation></ref><ref id="bib127"><element-citation publication-type="journal" id="sref127"><person-group person-group-type="author"><name><surname>Tuppen</surname><given-names>H.A.</given-names></name><name><surname>Blakely</surname><given-names>E.L.</given-names></name><name><surname>Turnbull</surname><given-names>D.M.</given-names></name><name><surname>Taylor</surname><given-names>R.W.</given-names></name></person-group><article-title>Mitochondrial DNA mutations and human disease</article-title><source>Biochimica et Biophysica Acta - Bioenergetics</source><volume>1797</volume><year>2010</year><fpage>113</fpage><lpage>128</lpage></element-citation></ref><ref id="bib128"><element-citation publication-type="journal" id="sref128"><person-group person-group-type="author"><name><surname>Valente</surname><given-names>L.</given-names></name><name><surname>Tiranti</surname><given-names>V.</given-names></name><name><surname>Marsano</surname><given-names>R.M.</given-names></name><name><surname>Malfatti</surname><given-names>E.</given-names></name><name><surname>Fernandez-Vizarra</surname><given-names>E.</given-names></name><name><surname>Donnini</surname><given-names>C.</given-names></name><name><surname>Mereghetti</surname><given-names>P.</given-names></name><name><surname>De Gioia</surname><given-names>L.</given-names></name><name><surname>Burlina</surname><given-names>A.</given-names></name><name><surname>Castellan</surname><given-names>C.</given-names></name><etal/></person-group><article-title>Infantile encephalopathy and defective mitochondrial DNA translation in patients with mutations of mitochondrial elongation factors EFG1 and EFTu</article-title><source>Am. J. Hum. Genet.</source><volume>80</volume><year>2007</year><fpage>44</fpage><lpage>58</lpage><pub-id pub-id-type="pmid">17160893</pub-id></element-citation></ref><ref id="bib129"><element-citation publication-type="journal" id="sref129"><person-group person-group-type="author"><name><surname>Valenti</surname><given-names>D.</given-names></name><name><surname>Braidy</surname><given-names>N.</given-names></name><name><surname>De Rasmo</surname><given-names>D.</given-names></name><name><surname>Signorile</surname><given-names>A.</given-names></name><name><surname>Rossi</surname><given-names>L.</given-names></name><name><surname>Atanasov</surname><given-names>A.G.</given-names></name><name><surname>Volpicella</surname><given-names>M.</given-names></name><name><surname>Henrion-Caude</surname><given-names>A.</given-names></name><name><surname>Nabavi</surname><given-names>S.M.</given-names></name><name><surname>Vacca</surname><given-names>R.A.</given-names></name></person-group><article-title>Mitochondria as pharmacological targets in Down syndrome</article-title><source>Free Radic. Biol. Med.</source><volume>114</volume><year>2018</year><fpage>69</fpage><lpage>83</lpage><pub-id pub-id-type="pmid">28838841</pub-id></element-citation></ref><ref id="bib130"><element-citation publication-type="journal" id="sref130"><person-group person-group-type="author"><name><surname>van den Ouweland</surname><given-names>J.M.</given-names></name><name><surname>Lemkes</surname><given-names>H.H.</given-names></name><name><surname>Ruitenbeek</surname><given-names>W.</given-names></name><name><surname>Sandkuijl</surname><given-names>L.A.</given-names></name><name><surname>de Vijlder</surname><given-names>M.F.</given-names></name><name><surname>Struyvenberg</surname><given-names>P.A.</given-names></name><name><surname>van de Kamp</surname><given-names>J.J.</given-names></name><name><surname>Maassen</surname><given-names>J.A.</given-names></name></person-group><article-title>Mutation in mitochondrial tRNA(Leu)(UUR) gene in a large pedigree with maternally transmitted type II diabetes mellitus and deafness</article-title><source>Nat. Genet.</source><volume>1</volume><year>1992</year><fpage>368</fpage><lpage>371</lpage><pub-id pub-id-type="pmid">1284550</pub-id></element-citation></ref><ref id="bib131"><element-citation publication-type="journal" id="sref131"><person-group person-group-type="author"><name><surname>Vantroys</surname><given-names>E.</given-names></name><name><surname>Larson</surname><given-names>A.</given-names></name><name><surname>Friederich</surname><given-names>M.</given-names></name><name><surname>Knight</surname><given-names>K.</given-names></name><name><surname>Swanson</surname><given-names>M.A.</given-names></name><name><surname>Powell</surname><given-names>C.A.</given-names></name><name><surname>Smet</surname><given-names>J.</given-names></name><name><surname>Vergult</surname><given-names>S.</given-names></name><name><surname>De Paepe</surname><given-names>B.</given-names></name><name><surname>Seneca</surname><given-names>S.</given-names></name><etal/></person-group><article-title>New insights into the phenotype of FARS2 deficiency</article-title><source>Mol. Genet. Metabol.</source><volume>122</volume><year>2017</year><fpage>172</fpage><lpage>181</lpage></element-citation></ref><ref id="bib132"><element-citation publication-type="journal" id="sref132"><person-group person-group-type="author"><name><surname>Villagomez</surname><given-names>A.N.</given-names></name><name><surname>Mu&#x000f1;oz</surname><given-names>F.M.</given-names></name><name><surname>Peterson</surname><given-names>R.L.</given-names></name><name><surname>Colbert</surname><given-names>A.M.</given-names></name><name><surname>Gladstone</surname><given-names>M.</given-names></name><name><surname>MacDonald</surname><given-names>B.</given-names></name><name><surname>Wilson</surname><given-names>R.</given-names></name><name><surname>Fairlie</surname><given-names>L.</given-names></name><name><surname>Gerner</surname><given-names>G.J.</given-names></name><name><surname>Patterson</surname><given-names>J.</given-names></name><etal/></person-group><article-title>Neurodevelopmental delay: case definition &#x00026; guidelines for data collection, analysis, and presentation of immunization safety data</article-title><source>Vaccine</source><volume>37</volume><year>2019</year><fpage>7623</fpage><lpage>7641</lpage><pub-id pub-id-type="pmid">31783983</pub-id></element-citation></ref><ref id="bib133"><element-citation publication-type="journal" id="sref133"><person-group person-group-type="author"><name><surname>Wallace</surname><given-names>D.C.</given-names></name></person-group><article-title>Mitochondrial genetic medicine</article-title><source>Nat. Genet.</source><volume>50</volume><year>2018</year><fpage>1642</fpage><lpage>1649</lpage><pub-id pub-id-type="pmid">30374071</pub-id></element-citation></ref><ref id="bib134"><element-citation publication-type="journal" id="sref134"><person-group person-group-type="author"><name><surname>Wynne</surname><given-names>M.E.</given-names></name><name><surname>Lane</surname><given-names>A.R.</given-names></name><name><surname>Singleton</surname><given-names>K.S.</given-names></name><name><surname>Zlatic</surname><given-names>S.A.</given-names></name><name><surname>Gokhale</surname><given-names>A.</given-names></name><name><surname>Werner</surname><given-names>E.</given-names></name><name><surname>Duong</surname><given-names>D.</given-names></name><name><surname>Kwong</surname><given-names>J.Q.</given-names></name><name><surname>Crocker</surname><given-names>A.J.</given-names></name><name><surname>Faundez</surname><given-names>V.</given-names></name></person-group><article-title>Heterogeneous expression of nuclear encoded mitochondrial genes distinguishes inhibitory and excitatory neurons</article-title><source>eNeuro</source><volume>8</volume><year>2021</year><object-id pub-id-type="publisher-id">ENEURO.0232-21.2021</object-id></element-citation></ref><ref id="bib135"><element-citation publication-type="journal" id="sref135"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>L.</given-names></name><name><surname>Garcia Canaveras</surname><given-names>J.C.</given-names></name><name><surname>Chen</surname><given-names>Z.</given-names></name><name><surname>Wang</surname><given-names>L.</given-names></name><name><surname>Liang</surname><given-names>L.</given-names></name><name><surname>Jang</surname><given-names>C.</given-names></name><name><surname>Mayr</surname><given-names>J.A.</given-names></name><name><surname>Zhang</surname><given-names>Z.</given-names></name><name><surname>Ghergurovich</surname><given-names>J.M.</given-names></name><name><surname>Zhan</surname><given-names>L.</given-names></name><etal/></person-group><article-title>Serine catabolism feeds NADH when respiration is impaired</article-title><source>Cell Metab.</source><volume>31</volume><year>2020</year><fpage>809</fpage><lpage>821.e6</lpage><pub-id pub-id-type="pmid">32187526</pub-id></element-citation></ref><ref id="bib136"><element-citation publication-type="journal" id="sref136"><person-group person-group-type="author"><name><surname>Yardeni</surname><given-names>T.</given-names></name><name><surname>Cristancho</surname><given-names>A.G.</given-names></name><name><surname>McCoy</surname><given-names>A.J.</given-names></name><name><surname>Schaefer</surname><given-names>P.M.</given-names></name><name><surname>McManus</surname><given-names>M.J.</given-names></name><name><surname>Marsh</surname><given-names>E.D.</given-names></name><name><surname>Wallace</surname><given-names>D.C.</given-names></name></person-group><article-title>An mtDNA mutant mouse demonstrates that mitochondrial deficiency can result in autism endophenotypes</article-title><source>Proc. Natl. Acad. Sci. USA</source><volume>118</volume><year>2021</year><object-id pub-id-type="publisher-id">e2021429118</object-id></element-citation></ref><ref id="bib137"><element-citation publication-type="journal" id="sref137"><person-group person-group-type="author"><name><surname>Yin</surname><given-names>X.</given-names></name><name><surname>Tang</surname><given-names>B.</given-names></name><name><surname>Mao</surname><given-names>X.</given-names></name><name><surname>Peng</surname><given-names>J.</given-names></name><name><surname>Zeng</surname><given-names>S.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Jiang</surname><given-names>H.</given-names></name><name><surname>Li</surname><given-names>N.</given-names></name></person-group><article-title>The genotypic and phenotypic spectrum of PARS2-related infantile-onset encephalopathy</article-title><source>J.&#x000a0;Hum. Genet.</source><volume>63</volume><year>2018</year><fpage>971</fpage><lpage>980</lpage><pub-id pub-id-type="pmid">29915213</pub-id></element-citation></ref><ref id="bib138"><element-citation publication-type="journal" id="sref138"><person-group person-group-type="author"><name><surname>Zabezhinsky</surname><given-names>D.</given-names></name><name><surname>Slobodin</surname><given-names>B.</given-names></name><name><surname>Rapaport</surname><given-names>D.</given-names></name><name><surname>Gerst</surname><given-names>J.E.</given-names></name></person-group><article-title>An essential role for COPI in mRNA localization to mitochondria and mitochondrial function</article-title><source>Cell Rep.</source><volume>15</volume><year>2016</year><fpage>540</fpage><lpage>549</lpage><pub-id pub-id-type="pmid">27068463</pub-id></element-citation></ref><ref id="bib139"><element-citation publication-type="journal" id="sref139"><person-group person-group-type="author"><name><surname>Zablotsky</surname><given-names>B.</given-names></name><name><surname>Black</surname><given-names>L.I.</given-names></name><name><surname>Maenner</surname><given-names>M.J.</given-names></name><name><surname>Schieve</surname><given-names>L.A.</given-names></name><name><surname>Danielson</surname><given-names>M.L.</given-names></name><name><surname>Bitsko</surname><given-names>R.H.</given-names></name><name><surname>Blumberg</surname><given-names>S.J.</given-names></name><name><surname>Kogan</surname><given-names>M.D.</given-names></name><name><surname>Boyle</surname><given-names>C.A.</given-names></name></person-group><article-title>Prevalence and trends of developmental disabilities among children in the United States: 2009-2017</article-title><source>Pediatrics</source><volume>144</volume><year>2019</year><object-id pub-id-type="publisher-id">e20190811</object-id></element-citation></ref><ref id="bib140"><element-citation publication-type="journal" id="sref140"><person-group person-group-type="author"><name><surname>Zheng</surname><given-names>X.</given-names></name><name><surname>Boyer</surname><given-names>L.</given-names></name><name><surname>Jin</surname><given-names>M.</given-names></name><name><surname>Mertens</surname><given-names>J.</given-names></name><name><surname>Kim</surname><given-names>Y.</given-names></name><name><surname>Ma</surname><given-names>L.</given-names></name><name><surname>Ma</surname><given-names>L.</given-names></name><name><surname>Hamm</surname><given-names>M.</given-names></name><name><surname>Gage</surname><given-names>F.H.</given-names></name><name><surname>Hunter</surname><given-names>T.</given-names></name></person-group><article-title>Metabolic reprogramming during neuronal differentiation from aerobic glycolysis to neuronal oxidative phosphorylation</article-title><source>Elife</source><volume>5</volume><year>2016</year><object-id pub-id-type="publisher-id">e13374</object-id></element-citation></ref><ref id="bib141"><element-citation publication-type="journal" id="sref141"><person-group person-group-type="author"><name><surname>Zinkstok</surname><given-names>J.R.</given-names></name><name><surname>Boot</surname><given-names>E.</given-names></name><name><surname>Bassett</surname><given-names>A.S.</given-names></name><name><surname>Hiroi</surname><given-names>N.</given-names></name><name><surname>Butcher</surname><given-names>N.J.</given-names></name><name><surname>Vingerhoets</surname><given-names>C.</given-names></name><name><surname>Vorstman</surname><given-names>J.A.S.</given-names></name><name><surname>van Amelsvoort</surname><given-names>T.A.M.J.</given-names></name></person-group><article-title>Neurobiological perspective of 22q11.2 deletion syndrome</article-title><source>Lancet Psychiatr.</source><volume>6</volume><year>2019</year><fpage>951</fpage><lpage>960</lpage></element-citation></ref></ref-list><ack id="ack0010"><title>Acknowledgments</title><p id="p0110">This work was supported by a grant from the <funding-source id="gs1"><institution-wrap><institution-id institution-id-type="doi">10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source> 1RF1AG060285 to V.F. V.F. is grateful for mitochondria provided by Maria Olga Gonzalez.</p><sec id="sec6"><title>Author contributions</title><p id="p0115">Conceptualization: P.B., V.F.; Visualization: V.F.; Writing&#x02014;original draft: P.B., V.F.; Writing&#x02014;review &#x00026; editing: P.B., A.P., V.F.</p></sec><sec sec-type="COI-statement" id="sec7"><title>Declaration of interests</title><p id="p0120">The authors declare no competing interests. Author V.F. is a member of the iScience Editorial Board.</p></sec></ack></back></article>
